The present invention relates to the field of lithium ion batteries, and more particularly, to electrolytes for preventing lithium metallization.
With continued success in the portable electronic device market, Li-ion batteries (LIBs) are of increasing interest for applications in electric and hybrid vehicles, surgical tools, and oil and gas drilling, etc., due to their superior energy density and long cycle life. However, current LIBs employ conventional liquid electrolytes based on organic solvents, which poses a safety concern, especially at elevated temperatures. Specifically, the use of carbonate solvents such as ethylene carbonate (EC), dimethyl carbonate (DMC), or diethyl carbonate (DEC) restricts battery operation to less than 60° C. due to their volatile and highly flammable nature. Moreover, when these solvents are used with Li salts, such as lithium hexafluorophosphate (LiPF6), a resistive film forms on the electrode surface affording poor cycle life. These side reactions become more dominating at higher temperatures as the rate of chemical reaction between the dissolved lithium salt and electrolyte solvent increases.
The following is a simplified summary providing an initial understanding of the invention. The summary does not necessarily identify key elements nor limit the scope of the invention, but merely serves as an introduction to the following description.
One aspect of the present invention provides a lithium ion cell comprising an anode and an electrolyte comprising at most 20% vol of at least one ionic liquid additive, wherein the anode comprises a surface layer configured to bond at least a portion of the at least one ionic liquid additive.
These, additional, and/or other aspects and/or advantages of the present invention are set forth in the detailed description which follows; possibly inferable from the detailed description; and/or learnable by practice of the present invention.
For a better understanding of embodiments of the invention and to show how the same may be carried into effect, reference will now be made, purely by way of example, to the accompanying drawings in which like numerals designate corresponding elements or sections throughout.
In the accompanying drawings:
In the following description, various aspects of the present invention are described. For purposes of explanation, specific configurations and details are set forth in order to provide a thorough understanding of the present invention. However, it will also be apparent to one skilled in the art that the present invention may be practiced without the specific details presented herein. Furthermore, well known features may have been omitted or simplified in order not to obscure the present invention. With specific reference to the drawings, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the present invention only, and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention, the description taken with the drawings making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.
Before at least one embodiment of the invention is explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is applicable to other embodiments that may be practiced or carried out in various ways as well as to combinations of the disclosed embodiments. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
The following analysis of lithium metallization and dendrite growth in some prior art anodes was used to define a problem which is solved by embodiments of the invention. The present disclosure is however not limited by the disclosed analysis, and is in general not bound by theory.
Embodiments of the present invention provide efficient and economical methods and mechanisms for preventing lithium metallization in lithium ion batteries (LIBs) and thereby provide improvements and enhancing safety in this technological field. It is suggested to use ionic liquids as an additive to prior art organic electrolyte 85 at low concentrations (e.g., up to 20% v/v) in order, e.g., to create a mobilized SEI (MSEI) zone during charging and dis-charging. These ionic liquids may be selected to be non-reactive or to have a very low reactivity toward metallic lithium. A surface layer on the anode material particles bonds (e.g., electrostatically and/or ionically) at least some of the ionic liquid additive to form an immobilized layer that provides further protection at the interface between the anode and the electrolyte, prevents metallization of lithium on the anode and decomposition of the electrolyte.
Electrolytes, anodes, lithium ion cells and methods are provided for preventing lithium metallization in lithium ion batteries to enhance their safety. Electrolytes comprise up to 20% ionic liquid additives which form a mobile solid electrolyte interface (mobile SEI or MSEI) during charging of the cell and prevent lithium metallization and electrolyte decomposition on the anode while maintaining the lithium ion mobility at a level which enables fast charging of the batteries. Anodes used with the present invention may be metalloid-based, for example the anodes may include silicon, germanium, tin and/or aluminum (as used herein, “metalloid-based”). However, the invention may also be applied for cells having graphite-based anodes.
In certain embodiments, a surface layer on the anode material particles may be applied to bond (e.g., electrostatically and/or ionically) at least some of the ionic liquid additive to form an immobilized layer (I/MSEI) that may provide further protection at the interface between the anode and the electrolyte, may prevent metallization of lithium on the former and decomposition of the latter. It is emphasizes that MSEI and/or I/MSEI may be created independently of each other, and possibly in addition to other types of SEI which may be formed in or at the surface of the anode material particles.
Advantageously, some embodiments of the invention provide alternative electrolytes with superior thermal and chemical stability, which expand the use of LIBs to a wider working temperature range without compromising the electrochemical performance. Moreover, some embodiments of the invention enable use of high energy metalloids and metals as anode active material, including C (graphite), as well as Si, Ge, Sn, Al, as disclosed e.g., in U.S. Pat. No. 9,472,804, filed on Nov. 12, 2015 and U.S. Pat. No. 9,406,927, filed on Feb. 4, 2016; and in U.S. application Ser. No. 14/813,499 filed on Jul. 30, 2015 which are incorporated herein by reference in their entirety. Advantageously, disclosed MSEI may prevent breaking and/or provide a healing mechanism for damage to fragile SEI layer(s) due to expansion and/or shrinkage of the anode. Moreover, disclosed embodiments reduce, to at least a partial extent during the cycle life of the LIB, decomposition of the electrolyte solvent at the interface with the metalloid, which may act as a catalytic surface due to lithium metal species at the interface such as lithium silicide (Li—Si).
Certain embodiments comprise anode material particles 110 comprising any of silicon active material, germanium active material and/or tin active material, possibly further comprising carbon material, boron and/or tungsten. As non-limiting examples, anode material particles 110 may comprise 5-50 weight % Si, 2-25 weight % B and/or 5-25 weight % W, and 0.01-15 weight % C (e.g., as carbon nanotubes, CNT); anode material particles 110 may comprise 5-80 weight % Ge, 2-20 weight % B and/or 5-20 weight % W, and 0.05-5 weight % C (e.g., as carbon nanotubes, CNT); anode material particles 110 may comprise 5-80 weight % Sn, 2-20 weight % B and/or 5-20 weight % W, and 0.5-5 weight % C (e.g., as carbon nanotubes, CNT); anode material particles 110 may comprise mixtures of Si, Ge and Sn, e.g., at weight ratios of any of at least 4:1 (Ge:Si), at least 4:1 (Sn:Si) or at least 4:1 (Sn+Ge):Si; anode material particles 110 may comprise aluminum and/or any of zinc, cadmium and/or lead, possibly with additions of borate and/or phosphate salt(s) as disclosed below.
Certain embodiments comprise anode material particles 110 comprising nanoparticles 102 attached thereto, such as any of B4C, WC, VC and TiN, possibly having a particle size range of 10-50 nm and providing 5-25 weight % of modified anode material particles 110A. Nanoparticles 102 may be configured to form in modified anode material particles 110A compounds such as Li2B4O7 (lithium tetra-borate salt, e.g., via 4Li+7MeO+2B4C→2Li2B4O7+C+7Me, not balanced with respect to C and O, with Me denoting active material such as Si, Ge, Sn etc.) or equivalent compounds from e.g., WC, VC, TiN, which have higher affinity to oxygen than the anode active material.
Certain embodiments comprise anode material particles 110 comprising coatings(s) 104 of any of lithium polymers, conductive polymers and/or hydrophobic polymers, such as e.g., any of lithium polyphosphate (Li(n)PP or LiPP), lithium poly-acrylic acid (Li(n)PAA or LiPAA), lithium carboxyl methyl cellulose (Li(n)CMC or LiCMC), lithium alginate (Li(n)Alg or LiAlg) and combinations thereof, with (n) denoting multiple attached Li; polyaniline or substituted polyaniline, polypyrroles or substituted polypyrroles and so forth.
Any of anode material particles 110, 110A, 110B may be coated by thin films (e.g., 1-50 nm, or 2-10 nm thick) of carbon (e.g., amorphous carbon, graphite, graphene, etc.) and/or transition metal oxide(s) (e.g., Al2O3, B2O3, TiO2, ZrO2, MnO etc.)
In certain embodiments, borate and/or phosphate salt(s) 102A may comprise borate salts such as lithium bis(oxalato)borate (LiBOB, LiB(C2O4)2), lithium difluoro(oxalato)borate (LiFOB, LiBF2(C2O4)), lithium tetraborate (LiB4O7), lithium bis(malonato)borate (LiBMB), lithium bis(trifluoromethanesulfonylimide) (LiTFSI). or any other compound which may lead to formation of borate salts (B2O3) on anode active material particles 110, including in certain embodiments B4C nanoparticles 102.
In certain embodiments, borate and/or phosphate salt(s) 102A may comprise phosphate salts such as lithium phosphate (LiPO4), lithium pyrophosphate (LiP2O7), lithium tripolyphosphate (LiP3O10) or any other compound which may lead to formation of phosphate salts (P2O5) on anode active material particles 110.
Certain embodiments comprise composite anode material particles 110B which may be configured as core shell particles (e.g., the shell being provided by any of coating(s) 104 and possible modifications presented above). The different configurations are illustrated schematically in different regions of the anode surface, yet embodiments may comprise any combinations of these configurations as well as any extent of anode surface with any of the disclosed configurations. Anode(s) 100 may then be integrated in cells 150 which may be part of lithium ion batteries, together with corresponding cathode(s) 87, electrolyte 105 and separator 86, as well as other battery components (e.g., current collectors, electrolyte additives—see below, battery pouch, contacts, and so forth).
Anode material particles 110, 110A, 110B, anodes 100 and cells 150 may be configured according to the disclosed principles to enable high charging and/or discharging rates, ranging from 3-10 C-rate, 10-100 C-rate or even above 100 C, e.g., 5 C, 10 C, 15 C, 30 C or more. It is noted that the term C-rate is a measure of charging and/or discharging of cell/battery capacity, e.g., with 1 C denoting charging and/or discharging the cell in an hour, and XC (e.g., 5 C, 10 C, 50 C etc.) denoting charging and/or discharging the cell in 1/X of an hour—with respect to a given capacity of the cell.
Examples for electrolyte 105 may comprise liquid electrolytes such as ethylene carbonate, diethyl carbonate, propylene carbonate, vinylene carbonate, fluoroethylene carbonate (FEC), and combinations thereof and/or solid electrolytes such as polymeric electrolytes such as polyethylene oxide, fluorine-containing polymers and copolymers (e.g., polytetrafluoroethylene), and combinations thereof. Electrolyte 105 may comprise lithium electrolyte salt(s) such as LiPF6, LiBF4, lithium bis(oxalato)borate, LiN(CF3SO2)2, LiN(C2F5SO2)2, LiAsF6, LiC(CF3SO2)3, LiClO4, LiTFSI, LiB(C2O4)2, LiBF2(C2O4)), tris(trimethylsilyl)phosphite (TMSP), lithuium 4,5-dicyano-2-(trifluoromethyl)imidazolide (LiTDI), and combinations thereof. Ionic liquid(s) 135 may be added to electrolyte 105 as disclosed below. Cathode(s) 87 may comprise various compositions, such as LiCoO2, LiCo0.33Mn0.33Ni0.33O2, LiMn2O4, LiFePO4 and/or combinations thereof. Separator(s) 87 may comprise various materials, such as polyethylene (PE), polypropylene (PP) or other appropriate materials.
In certain embodiments, electrolyte 105 may comprise ionic liquid additive 135 (e.g., at 20%, 10%, 5%, 2%, 1% v/v or any other volume part smaller than 20%), added to prior art electrolyte 85, which is selected to at least partially provide anions 131 and/or cations 132 to build electrolyte-buffering zone(s) 130. For example, ionic liquid additive 135 may comprise acidic groups which are selected to be anionic in the environment of lithium ions 91. Anions 131 and/or cations 132 may be relatively large to form a barrier which reduces the approaching speed of lithium ions 91 and which locally increases the resistance of electrolyte-buffering zone(s) 130 to lithium ions 91 to prevent or attenuate accumulation of lithium ions 91 at the surface of anode 100 (illustrated e.g., with respect to anode material particles 110).
Ionic liquid additive 135 may be selected to be not reactive in the cell, not to be reactive with lithium metal (e.g., not decompose in the presence of lithium metal) and not to intercalate with active material 110 of anode 100. The ionic strength and lithium ion mobility may be selected to appropriate values and the ionic conductivity may be controlled in a better way than a single component electrolyte 85. Moreover, ionic liquid additive 135 may be selected to have large volume anions 131 and cations 132 (illustrated schematically in
Ionic liquid additive 135 may be selected to enable lithium ion transport therethrough while partly reducing the lithium ions and keep them in a partly charged form Liδ+ in zone 130.
Under various configurations of anodes 100, cracks may appear in surface layer 115 of anode, which may comprise or support a SEI (which may be brittle), a coating and/or a buffering zone. Such cracks may enable renewed contact between the anode material and/or metal lithium and electrolyte 85, or increase the surface area available for such contact—causing further electrolyte decomposition and possible sites for lithium metallization. Ionic liquid additive 135 may be configured to fill in such cracks 114 (illustrated schematically in
Without being bound by theory, the mechanism of MSEI formation may be both concentration and kinetically controlled, e.g., the more ionic liquid additive 135 is separated from electrolyte 105, the faster mobile SEI layer 130 forms; while an increase of the concentration of ionic liquid additive 135 may reduce the ionic mobility through MSEI 130. The concentration of ionic liquid additive 135 may thus be selected to balance reduced ionic mobility by higher concentration with possible electrolyte decomposition on the active material-electrolyte interface which may be enabled by too low concentrations of ionic liquid additive 135 (which forms MSEI 130 too slowly). Moreover, using ionic liquid additive 135 may maintain or enhance the ionic strength, without compromising the ionic mobility by increasing the ionic resistance, by enabling a reduction of the lithium salt (e.g., LiPF6) concentration, which also further reduces the probability for metallization.
In embodiments, the ionic liquid additive contains a nitrogen atom with a charge. Non-limiting examples of ionic liquid additives 135 include. without limitation, any of the following and their combinations: 1-butyl-1-methylpyrrolidinium as cation 132 and bis(trifluoromethanesulfonyl)imide as anion 131 (melting point −6° C.); 1-butyl-3-methylimidazolium as cation 132 and bis(trifluoromethanesulfonyl)imide as anion 131 (melting point −4° C.); 1-butyl-3-methylimidazolium as cation 132 and bis(fluorosulfonyl)imide as anion 131 (melting point −13° C.); N,N-Diethyl-N-methyl-N-propylammonium as cation 132 and bis(fluorosulfonyl)imide as anion 131; and N-propyl-N-methylpiperidinium as cation 132 and bis(trifluoromethanesulfonyl)imide as anion 131. Certain embodiments comprise ionic liquids which are derived from these combinations, i.e., having various substituents. As illustrated in the examples above, ionic liquid additives 135 may be based on sulfonylimides as anions 131 and on piperidinium derivatives as cations 132, referred to below as ionic liquids based on sulfonylimides and piperidinium derivatives.
Advantageously, certain embodiments use, as ionic liquid additives 135, ionic liquids having a negligible vapor pressure and which are liquid at room temperature, a wide electrochemical potential window (e.g., up to 5.0 V in ionic liquids based on sulfonylimides and piperidinium derivatives), and structural stability across a large temperature range (e.g., up to 385° C. in ionic liquids based on sulfonylimides and piperidinium derivatives). For example, the ionic liquids may have melting temperatures of 10-20° C., 0-10° C., or possibly even <0° C., e.g., 0-−4° C., −4°-−13° C., or even lower, e.g., below −20° C., having melting points down to −40° C., as non-limiting examples. The lithium ion conductivity in certain ionic liquids based on sulfonylimides and piperidinium derivatives at room temperature may be, for example, between 1-20 mS/cm (at 20° C.), in some embodiments, between 1.4-15.4 mS/cm (at 20° C.), wherein exact values can be provided according to requirements.
The use of ionic liquids as additive 135 solves prior art problems in attempting to use ionic liquids as electrolytes 85, such as their high viscosity and low Li-ion conductivity at room temperature and reduced cathodic stability. Their use as additives 135 (e.g., up to 20% vol of electrolyte 105, the rest comprising electrolyte 85) mitigates their prior art disadvantages and utilizes their advantageous property exactly where needed, e.g., at the anode-electrolyte interface. Moreover, the use of ionic liquids based on sulfonylimides and piperidinium derivatives with C (e.g., graphite), or metalloid (e.g., Si, Sn, Ge or Al)-based anodes solves prior art problems of co-intercalation of the piperidinium cations along with the Li-ion in graphite-based electrodes at lower potentials during the charge-discharge process—as metalloid-based anodes do not co-intercalate the piperidinium cations. Nevertheless, some embodiments comprise using disclosed electrolytes 105 with ionic liquid additives 135 in lithium ion cells employing graphite anodes.
For example, in quantitative, non-limiting examples, assuming germanium as anode active material which may reach 270% expansion upon lithiation, and particle diameter of 100 nm, the surface area per particle upon lithiation may increase from ca. 31,000 nm2 to ca. 61,000 nm2. Depending on the number of required ionic liquid additive molecular layers 130(1 . . . n) and on the molecule area, the number of required ionic liquid molecules for covering the overall surface area of the anode active material particles may be calculated. For example, in a non-limiting calculation assuming three layers (n=3) at the maximal expansion of the particles and N,N-Diethyl-N-methyl-N-propylammonium (cation 132) and bis(fluorosulfonyl)imide (anion 131) as ionic liquid additive 135 (relating to cations 132 thereof for molecule size calculation—ca. 0.3 nm2), ca. 620,000 molecules are required per particle, or ca. 10−18 mol ionic liquid additive 135. Proceeding with estimating the overall number of particles, their mass, the molar weight of the electrolyte and the ionic liquid additive, the volume % of ionic liquid additive 135 may be calculated. For example, for 70% active material in the anode, the number of particle was estimated as ca. 5·1011, requiring ca. 5·10−7 mol of ionic liquid additive 135 which is equivalent to ca. 0.05 mol/liter ionic liquid additive in electrolyte 105 (assuming electrolyte 85 comprising FEC:DMC (3:7) and 2% VC—FEC denoting fluorinated ethylene carbonates, DMC denoting dimethyl carbonate and VC denoting vinylene carbonate), or ca. 1.2% vol of ionic liquid additive 135 in electrolyte 105. Clearly, any adaptation of electrolyte 105 with respect to its ingredients, as well as any modification of the required number of layers 130 (e.g., n=1, 2, 5, 10 etc.) in expanded state yields different percentage, which may be taken into account when preparing electrolyte 105. For example, in certain embodiments, ionic liquid additive 135 concentration of 0.4% vol may be sufficient to provide one layer 130 at most expanded state of anode material particles 110 which corresponds to full lithiation. In other embodiments, lower percentage of active material in the anode may require using less ionic liquid additive 135, but not necessarily at a linear relation.
Similar calculations may be carried out for other anode active materials such as silicon (which may reach 400% expansion upon lithiation), tin (which may reach 330% expansion upon lithiation), alloys and/or mixtures thereof (with or without germanium) which may have intermediate expansion coefficients, and even less expanding anode active materials such as graphite (which typically expands by 10% upon intercalation), LTO (lithium titanate oxide) with minimal expansion (0.02%). Similar calculations may be carried out with respect to particle sizes and surface area, various types of ionic liquid 135 and various types of electrolyte 105, which are disclosed herein. The calculations presented above may be modified to determine the required concentration of ionic liquid additive 135 in electrolyte 105 using the corresponding materials.
Concluding from the examples presented above, the concentration of ionic liquid additive 135 in electrolyte 105 may be determined according to the disclosed guidelines and may vary greatly from embodiment to embodiment. While large concentrations of up to 20% may be used, some embodiments may comprise lower concentrations of 1% vol, 1-0.1% vol, 2-0.1% vol, or possibly even concentrations lower than 0.1%.
In some embodiments, the bonding of ions of ionic liquid additive(s) 135 may involve bonding cations 132 or possibly anions 131 by bonding molecules 116 as the layer closest to surface 112. The bonding may be carried out during one or more first charging and discharging cycles of cell 150. In certain embodiments, the bonding of cations 132 and/or anions 131 may be carried out, at least partially, on active material 110 itself, even before the first charging cycle. The bonding of the ionic liquid to bonding layer 145 may be electrostatic and/or salt-like (ionic). In certain embodiments, the bonding may be at least partly covalent. The bonding may involve any number of ionic layers, typically a few layers, possibly providing a salt layer which isolates the organic solvent used for electrolyte 85 at least from active material 110 of anode 100.
Bonding molecules 116 may be ionic or have electron rich groups such as sodium aniline sulfonate. Bonding molecules 116 may comprise lithium cations and/or possibly magnesium cations, the latter possibly when the anode material is graphite. Non-limiting examples for bonding molecules 116 comprise lithium alkylsulfonate, poly(lithium alkylsulfonate), lithium sulfate, lithium phosphate, lithium phosphate monobasic, alkylhydroxamate salts and their acidic forms (e.g., lithium sulfonic acid, LiHSO4, instead of lithium sulfonate, Li2SO4). In case of aluminum as anode material, bonding molecules 116 may comprise lithium cations and/or aluminum cations. The lithium in the following examples may thus be replaced in some embodiments by magnesium and/or aluminum. In case of graphite anodes, a wide range of activation techniques which yield oxidized graphite may be used to enhance chemical bonding of molecules 116 (e.g., using halides or alkoxides). See below an elaboration of bonding molecules 116 and their characteristics.
The chemical bonding of molecules 116 to anode 100 (e.g., to anode material particles 110) may be carried out, for example, in the anode slurry solution and/or in dry ball milling with anode material particles. The bonding mechanism may comprise, e.g., reaction(s) of the lithium sulfonates and/or salts with metal oxides, releasing the oxide and creating a direct chemical bond to metalloid surface 112, where the lithium cation remain partly charged (Liδ+) in the metalloid. For example, using a large volume salt with an additional anion group as bonding molecules 116 may create a salt surface 145 on metalloid material 110, which can both protect the interface and co-operate with ionic liquid additive 135 in electrolyte 105. Layer 145 may bind a stationary portion of ionic liquid additive 135 on metalloid surface 112 while the rest of ionic liquid additive 135 is mobilized in electrolyte 105, providing a hybrid ionic liquid additive which is partly bonded and partly free in electrolyte 105. Stationary portion 140A may increase the re-ordering rate of ionic liquid additive 135 on surface 115 during charging (101C), help repel organic electrolyte 85 from the interface and hence reduce the probability for the decomposition of the organic solvent. Non-limiting examples for bonding molecules 116 include large anionic salts or their acids which may be selected to sterically repel the smaller organic carbonates solvents (of electrolyte 85) from active material surface 112. Layer 145 and stationary portion 140A of ionic liquid additive 135 on metalloid surface 112 may be highly effective during the initial charging, and enable or support the building of a stable SEI during the formation cycle(s) which protects surface 112 and anode 100 during later operation, and prevent decomposition of electrolyte on anode 100 as well as lithium metallization thereupon.
The resulting SEI may be modified toward enhanced stability and be possibly provided with self-healing mechanisms through layer 145 and stationary portion 140A of ionic liquid additive 135.
In some embodiments, bonding molecules 116 are represented by formula I:
In some embodiments, bonding molecules 116 are represented by formula II:
In some embodiments, bonding molecules 116 are represented by formula III:
In some embodiments, bonding molecules 116 are represented by formula IV:
In some embodiments, bonding molecules 116 are represented by formula V:
In some embodiments, bonding molecules 116 are represented by formula VI:
In some embodiments, bonding molecules 116 are represented by formula VII:
In some embodiments, bonding molecules 116 may be polymers, possibly crosslinked with inorganic crosslinkers. Non limiting examples of polymers include polymers represented by formula VI, polyvinylalcohol (PVA), polymethylmetacrylate (PMMA), polyacrylic acid (PAA), polyethylene glycol (PEG), polyvinylsulfonic acid and polyvinylpyrrolidone (PVP), or any combination thereof. Non limiting examples of inorganic crosslinkers include boron (B) oxides, zirconium complexes and tetralkoxysilanes or any combination thereof. Non limiting examples of boron (B) oxides include boric acid (H3BO3), salts of tetraborate (B4O72−) and boron trioxide (B2O3). In some embodiments, salts of tetraborate (B4O72−) are selected from the anion tetraborate and a cation of alkali metal or alkaline earth metal, aluminum cation (Al3+) or any combination thereof. In some embodiments, the boron (B) oxide is a lithium tetraborate salt (Li2B4O7) (and see also borate salts 102A). Non limiting examples of zirconium complexes include zirconium complex of tetra-2-hydroxypropyl ethylenediamine and ammonium zirconium carbonate. Non limiting examples of tetraalkoxysilane include teraethoxysilane and tetrapropoxyisilane.
In some embodiments, bonding molecules 116 may comprise salts comprising cations selected from H+, Li, Na, K, Rb, Cs, Be, Mg, Ca, Sr and Ba, Al3+ or any combination thereof and anions selected from RCOO−, RSO3−, RPO32−, RPO42− or any combination thereof. In some embodiments, the salt is lithium sulfate (Li2SO4). In some embodiments, the salt is lithium phosphate monobasic (H2LiPO4). In some embodiments, the salt is lithium phosphate (Li3PO4). In some embodiments, the salt is phosphoric acid (H3PO4).
In some embodiments, bonding molecules 116 are represented at least by one of formulas I-VH.
In some embodiments, the invention is directed to a lithium ion cell comprising a modified graphite anode, represented by the formula Gr-Bz, wherein Gr is graphite anode and Bz is a benzyl moiety. In some embodiments, a benzyl moiety with a good leaving group is reacted with graphite anode and also with a non-nucleophilic base to form a modified graphite anode, wherein the graphite is attached covalently to the CH2 moiety of the benzylic compound. Non-limiting examples of non-nucleophilic bases include 1,8-Diazabicyclo(5.4.0)undec-7-ene (DBU), N,N-Diisopropylethylamine (DIPEA) and 2,6-Di-tert-butylpyridine. In some embodiments, the non-nucleophilic base is 1,8-Diazabicyclo(5.4.0)undec-7-ene (DBU). In some embodiments the non-nucleophilic base is N,N-Diisopropylethylamine (DIPEA). In some embodiments the non-nucleophilic base is 2,6-Di-tert-butylpyridine. In some embodiments the non-nucleophilic base is any combination of the above referenced non nucleophilic bases. Non limiting examples of good leaving groups are selected from halides (e.g., Cl, Br, I), mesylate, triflate and tosylate.
In some embodiments, the invention directs to a lithium ion cell comprising a modified graphite anode, represented by the formula Gr-SR, wherein Gr is graphite anode, SR is a thiolether moiety, wherein R is selected from alkyl, haloalkyl, cycloalkyl, heterocycloalkyl, aryl, and benzyl. In some embodiments, a thiol, RSH, is reacted with graphite anode and a radical initiator, to form a modified graphite anode, wherein the graphite is attached covalently to the S atom of the thiolether compound. Non-limiting examples of a radical initiator include azo compounds such as azobisisobutyronitrile (AIBN) and 1,1′-Azobis(cyclohexanecarbonitrile) (ABCN), organic peroxides such as benzoyl peroxide and ditertbutylperoxide and inorganic peroxides, e.g. peroxydisulfate. In some embodiments, the radical initiator is azobisisobutyronitrile (AIBN). In some embodiments, the radical initiator is 1,1′-Azobis(cyclohexanecarbonitrile) (ABCN). In some embodiments, the radical initiator is benzoyl peroxide. In some embodiments, the radical initiator is ditertbutylperoxide. In some embodiments, the radical initiator is peroxydisulfate. In some embodiments, the radical initiator is any combination of the above referenced radical initiators.
In some embodiments, the invention directs to a lithium ion cell comprising a modified Si anode. In some embodiments, the Si anode is connected covalently to bonding molecule 116, represented by formula I-VII. In some embodiments, a Si anode rich in silanol bonds, Si—OH, is reacted with the bonding molecule to afford the modified Si anode. In some embodiments, a Si anode rich in silanol bonds, Si—OH, is reacted with Si(OR)3 moiety in the bonding molecule to afford the modified Si anode. In some embodiments, bonding molecule 116, represented by formula I-VII, is connected to the Si anode via silanol linkage, Si—O—Si.
In some embodiments, Z is aryl, heterocycloalkyl, crown etheryl, cyclamyl, cyclenyl, cryptandyl, naphthalenyl, anthracenyl, phenanthrenyl, tetracenyl, chrysenyl, triphenylenyl pyrenyl or pentacenyl. In some embodiments, Z is aryl. In some embodiments, Z is heterocycloalkyl. In some embodiments, Z is crown etheryl. In some embodiments, Z is cyclamyl. In some embodiments, Z is cyclenyl. In some embodiments, Z is cryptandyl. In some embodiments, Z is naphthalenyl. In some embodiments, Z is anthracenyl. In some embodiments, Z is anthracenyl. In some embodiments, Z is phenanthrenyl. In some embodiments, Z is tetracenyl. In some embodiments, Z is chrysenyl. In some embodiments, Z is triphenylenyl. In some embodiments, Z is pyrenyl. In some embodiments, Z is pentacenyl.
In some embodiments, L1 is H, F or R101. In some embodiments, L1 is H. In some embodiments, L1 is F. In some embodiments, L1 is R101.
In some embodiments, L2 is H, F or R102. In some embodiments, L2 is H. In some embodiments, L2 is F. In some embodiments, L2 is R102.
In some embodiments, L3 is H, F or R104. In some embodiments, L3 is H. In some embodiments, L3 is F. In some embodiments, L3 is R104.
In some embodiments, L4 is H, F or R106. In some embodiments, L4 is H. In some embodiments, L4 is F. In some embodiments, L4 is R106.
In some embodiments, R2 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R2 is CO2H. In some embodiments, R2 is CO2M1. In some embodiments, R2 is CO2R. In some embodiments, R2 is SO3H. In some embodiments, R2 is SO3M1. In some embodiments, R2 is PO3H2. In some embodiments, R2 is PO3M12. In some embodiments, R2 is PO3M1H. In some embodiments, R2 is PO4H2. In some embodiments, R2 is PO4M12. In some embodiments, R2 is PO4M1H. In some embodiments, R2 is PO4M2. In some embodiments, R2 is C(O)NHOH. In some embodiments, R2 is NH2. In some embodiments, R2 is NHR. In some embodiments, R2 is N(R)2. In some embodiments, R2 is NO2. In some embodiments, R2 is COOR. In some embodiments, R2 is CHO. In some embodiments, R2 is CH2OH. In some embodiments, R2 is OH. In some embodiments, R2 is OR. In some embodiments, R3 is SH. In some embodiments, R2 is SR. In some embodiments, R2 is C(O)N(R)2. In some embodiments, R2 is C(O)NHR. In some embodiments, R2 is C(O)NH2. In some embodiments, R2 is halide. In some embodiments, R2 is tosylate. In some embodiments, R2 is mesylate. In some embodiments, R2 is SO2NHR. In some embodiments, R2 is triflate. In some embodiments, R2 is isocyanate. In some embodiments, R2 is cyanate. In some embodiments, R2 is thiocyanate. In some embodiments, R2 is isothiocyanate. In some embodiments, R2 is R. In some embodiments, R2 is cyano. In some embodiments, R2 is CF3. In some embodiments, R2 is Si(OR)3.
In some embodiments, R3 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R3 is CO2H. In some embodiments, R3 is CO2M1. In some embodiments, R3 is CO2R. In some embodiments, R3 is SO3H. In some embodiments, R3 is SO3M1. In some embodiments, R3 is PO3H2. In some embodiments, R3 is PO3M12. In some embodiments, R3 is PO3M1H. In some embodiments, R3 is PO4H2. In some embodiments, R3 is PO4M12. In some embodiments, R3 is PO4M1H. In some embodiments, R3 is PO4M2. In some embodiments, R3 is C(O)NHOH. In some embodiments, R3 is NH2. In some embodiments, R3 is NHR. In some embodiments, R3 is N(R)2. In some embodiments, R3 is NO2. In some embodiments, R3 is COOR. In some embodiments, R3 is CHO. In some embodiments, R3 is CH2OH. In some embodiments, R3 is OH. In some embodiments, R3 is OR. In some embodiments, R3 is SH. In some embodiments, R3 is SR. In some embodiments, R3 is C(O)N(R)2. In some embodiments, R3 is C(O)NHR. In some embodiments, R3 is C(O)NH2. In some embodiments, R3 is halide. In some embodiments, R3 is tosylate. In some embodiments, R3 is mesylate. In some embodiments, R3 is SO2NHR. In some embodiments, R3 is triflate. In some embodiments, R3 is isocyanate. In some embodiments, R3 is cyanate. In some embodiments, R3 is thiocyanate. In some embodiments, R3 is isothiocyanate. In some embodiments, R3 is R. In some embodiments, R3 is cyano. In some embodiments, R3 is CF3. In some embodiments, R3 is Si(OR)3.
In some embodiments, R4 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R4 is CO2H. In some embodiments, R4 is CO2M1. In some embodiments, R4 is CO2R. In some embodiments, R4 is SO3H. In some embodiments, R4 is SO3M1. In some embodiments, R4 is PO3H2. In some embodiments, R4 is PO3M12. In some embodiments, R4 is PO3M1H. In some embodiments, R4 is PO4H2. In some embodiments, R4 is PO4M12. In some embodiments, R4 is PO4M1H. In some embodiments, R4 is PO4M2. In some embodiments, R4 is C(O)NHOH. In some embodiments, R4 is NH2. In some embodiments, R4 is NHR. In some embodiments, R4 is N(R)2. In some embodiments, R4 is NO2. In some embodiments, R4 is COOR. In some embodiments, R4 is CHO. In some embodiments, R4 is CH2OH. In some embodiments, R4 is OH. In some embodiments, R4 is OR. In some embodiments, R4 is SH. In some embodiments, R4 is SR. In some embodiments, R4 is C(O)N(R)2. In some embodiments, R4 is C(O)NHR. In some embodiments, R4 is C(O)NH2. In some embodiments, R4 is halide. In some embodiments, R4 is tosylate. In some embodiments, R4 is mesylate. In some embodiments, R4 is SO2NHR. In some embodiments, R4 is triflate. In some embodiments, R4 is isocyanate. In some embodiments, R4 is cyanate. In some embodiments, R4 is thiocyanate. In some embodiments, R4 is isothiocyanate. In some embodiments, R4 is R. In some embodiments, R4 is cyano. In some embodiments, R4 is CF3. In some embodiments, R4 is Si(OR)3.
In some embodiments, R5 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R5 is CO2H. In some embodiments, R5 is CO2M1. In some embodiments, R5 is CO2R. In some embodiments, R5 is SO3H. In some embodiments, R5 is SO3M1. In some embodiments, R5 is PO3H2. In some embodiments, R5 is PO3M12. In some embodiments, R5 is PO3M1H. In some embodiments, R5 is PO4H2. In some embodiments, R5 is PO4M12. In some embodiments, R5 is PO4M1H. In some embodiments, R5 is PO4M2. In some embodiments, R5 is C(O)NHOH. In some embodiments, R5 is NH2. In some embodiments, R5 is NHR. In some embodiments, R5 is N(R)2. In some embodiments, R5 is NO2. In some embodiments, R5 is COOR. In some embodiments, R5 is CHO. In some embodiments, R5 is CH2OH. In some embodiments, R5 is OH. In some embodiments, R5 is OR. In some embodiments, R5 is SH. In some embodiments, R5 is SR. In some embodiments, R5 is C(O)N(R)2. In some embodiments, R5 is C(O)NHR. In some embodiments, R5 is C(O)NH2. In some embodiments, R5 is halide. In some embodiments, R5 is tosylate. In some embodiments, R5 is mesylate. In some embodiments, R5 is SO2NHR. In some embodiments, R5 is triflate. In some embodiments, R5 is isocyanate. In some embodiments, R5 is cyanate. In some embodiments, R5 is thiocyanate. In some embodiments, R5 is isothiocyanate. In some embodiments, R5 is R. In some embodiments, R5 is cyano. In some embodiments, R5 is CF3. In some embodiments, R5 is Si(OR)3.
In some embodiments, R6 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R6 is CO2H. In some embodiments, R6 is CO2M1. In some embodiments, R6 is CO2R. In some embodiments, R6 is SO3H. In some embodiments, R6 is SO3M1. In some embodiments, R6 is PO3H2. In some embodiments, R6 is PO3M12. In some embodiments, R6 is PO3M1H. In some embodiments, R6 is PO4H2. In some embodiments, R6 is PO4M12. In some embodiments, R6 is PO4M1H. In some embodiments, R6 is PO4M2. In some embodiments, R6 is C(O)NHOH. In some embodiments, R6 is NH2. In some embodiments, R6 is NHR. In some embodiments, R6 is N(R)2. In some embodiments, R6 is NO2. In some embodiments, R6 is COOR. In some embodiments, R6 is CHO. In some embodiments, R6 is CH2OH. In some embodiments, R6 is OH. In some embodiments, R6 is OR. In some embodiments, R6 is SH. In some embodiments, R6 is SR. In some embodiments, R5 is C(O)N(R)2. In some embodiments, R5 is C(O)NHR. In some embodiments, R5 is C(O)NH2. In some embodiments, R6 is halide. In some embodiments, R6 is tosylate. In some embodiments, R6 is mesylate. In some embodiments, R6 is SO2NHR. In some embodiments, R6 is triflate. In some embodiments, R6 is isocyanate. In some embodiments, R6 is cyanate. In some embodiments, R6 is thiocyanate. In some embodiments, R6 is isothiocyanate. In some embodiments, R6 is R. In some embodiments, R6 is cyano. In some embodiments, R6 is CF3. In some embodiments, R6 is Si(OR)3.
In some embodiments, R8 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R8 is CO2H. In some embodiments, R8 is CO2M1. In some embodiments, R8 is CO2R. In some embodiments, R8 is SO3H. In some embodiments, R8 is SO3M1. In some embodiments, R8 is PO3H2. In some embodiments, R8 is PO3M12. In some embodiments, R5 is PO3M1H. In some embodiments, R8 is PO4H2. In some embodiments, R8 is PO4M12. In some embodiments, R8 is PO4M1H. In some embodiments, R8 is PO4M2. In some embodiments, R8 is C(O)NHOH. In some embodiments, R8 is NH2. In some embodiments, R8 is NHR. In some embodiments, R8 is N(R)2. In some embodiments, R8 is NO2. In some embodiments, R8 is COOR. In some embodiments, R8 is CHO. In some embodiments, R8 is CH2OH. In some embodiments, R8 is OH. In some embodiments, R8 is OR. In some embodiments, R8 is SH. In some embodiments, R8 is SR. In some embodiments, R8 is C(O)N(R)2. In some embodiments, R8 is C(O)NHR. In some embodiments, R8 is C(O)NH2. In some embodiments, R8 is halide. In some embodiments, R8 is tosylate. In some embodiments, R8 is mesylate. In some embodiments, R8 is SO2NHR. In some embodiments, R8 is triflate. In some embodiments, R8 is isocyanate. In some embodiments, R8 is cyanate. In some embodiments, R8 is thiocyanate. In some embodiments, R8 is isothiocyanate. In some embodiments, R8 is R. In some embodiments, R8 is cyano. In some embodiments, R8 is CF3. In some embodiments, R8 is Si(OR)3.
In some embodiments, R9 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano, CF3 or Si(OR)3. In some embodiments, R9 is CO2H. In some embodiments, R9 is CO2M1. In some embodiments, R9 is CO2R. In some embodiments, R9 is SO3H. In some embodiments, R9 is SO3M1. In some embodiments, R9 is PO3H2. In some embodiments, R9 is PO3M12. In some embodiments, R9 is PO3M1H. In some embodiments, R9 is PO4H2. In some embodiments, R9 is PO4M12. In some embodiments, R9 is PO4M1H. In some embodiments, R9 is PO4M2. In some embodiments, R9 is C(O)NHOH. In some embodiments, R9 is NH2. In some embodiments, R9 is NHR. In some embodiments, R9 is N(R)2. In some embodiments, R9 is NO2. In some embodiments, R9 is COOR. In some embodiments, R9 is CHO. In some embodiments, R9 is CH2OH. In some embodiments, R9 is OH. In some embodiments, R9 is OR. In some embodiments, R5 is SH. In some embodiments, R9 is SR. In some embodiments, R9 is C(O)N(R)2. In some embodiments, R9 is C(O)NHR. In some embodiments, R9 is C(O)NH2. In some embodiments, R9 is halide. In some embodiments, R9 is tosylate. In some embodiments, R9 is mesylate. In some embodiments, R9 is SO2NHR. In some embodiments, R9 is triflate. In some embodiments, R9 is isocyanate. In some embodiments, R9 is cyanate. In some embodiments, R9 is thiocyanate. In some embodiments, R9 is isothiocyanate. In some embodiments, R9 is R. In some embodiments, R9 is cyano. In some embodiments, R9 is CF3. In some embodiments, R9 is Si(OR)3.
In some embodiments, R10 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R10 is CO2H. In some embodiments, R10 is CO2M1. In some embodiments, R10 is CO2R. In some embodiments, R10 is SO3H. In some embodiments, R10 is SO3M1. In some embodiments, R10 is PO3H2. In some embodiments, R10 is PO3M12. In some embodiments, R10 is PO3M1H. In some embodiments, R10 is PO4H2. In some embodiments, R10 is PO4M12. In some embodiments, R10 is PO4M1H. In some embodiments, R10 is PO4M2. In some embodiments, R10 is C(O)NHOH. In some embodiments, R10 is NH2. In some embodiments, R10 is NHR. In some embodiments, R10 is N(R)2. In some embodiments, R10 is NO2. In some embodiments, R10 is COOR. In some embodiments, R10 is CHO. In some embodiments, R10 is CH2OH. In some embodiments, R10 is OH. In some embodiments, R10 is OR. In some embodiments, R10 is SH. In some embodiments, R10 is SR. In some embodiments, R10 is C(O)N(R)2. In some embodiments, R10 is C(O)NHR. In some embodiments, R10 is C(O)NH2. In some embodiments, R10 is halide. In some embodiments, R10 is tosylate. In some embodiments, R10 is mesylate. In some embodiments, R10 is SO2NHR. In some embodiments, R10 is triflate. In some embodiments, R10 is isocyanate. In some embodiments, R10 is cyanate. In some embodiments, R10 is thiocyanate. In some embodiments, R10 is isothiocyanate. In some embodiments, R10 is R. In some embodiments, R10 is cyano. In some embodiments, R10 is CF3. In some embodiments, R10 is Si(OR)3.
In some embodiments, R11 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R11 is CO2H. In some embodiments, R11 is CO2M1. In some embodiments, R11 is CO2R. In some embodiments, R11 is SO3H. In some embodiments, R11 is SO3M1. In some embodiments, R11 is PO3H2. In some embodiments, R11 is PO3M12. In some embodiments, R11 is PO3M1H. In some embodiments, R11 is PO4H2. In some embodiments, R11 is PO4M12. In some embodiments, R11 is PO4M1H. In some embodiments, R11 is PO4M2. In some embodiments, R11 is C(O)NHOH. In some embodiments, R11 is NH2. In some embodiments, R11 is NHR. In some embodiments, R11 is N(R)2. In some embodiments, R11 is NO2. In some embodiments, R11 is COOR. In some embodiments, R11 is CHO. In some embodiments, R11 is CH2OH. In some embodiments, R11 is OH. In some embodiments, R11 is OR. In some embodiments, R11 is SH. In some embodiments, R11 is SR. In some embodiments, R11 is C(O)N(R)2. In some embodiments, R11 is C(O)NHR. In some embodiments, R11 is C(O)NH2. In some embodiments, R11 is halide. In some embodiments, R11 is tosylate. In some embodiments, R11 is mesylate. In some embodiments, R11 is SO2NHR. In some embodiments, R11 is triflate. In some embodiments, R11 is isocyanate. In some embodiments, R11 is cyanate. In some embodiments, R11 is thiocyanate. In some embodiments, R11 is isothiocyanate. In some embodiments, R11 is R. In some embodiments, R11 is cyano. In some embodiments, R11 is CF3. In some embodiments, R11 is Si(OR)3.
In some embodiments, R12 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R12 is CO2H. In some embodiments, R12 is CO2M1. In some embodiments, R12 is CO2R. In some embodiments, R12 is SO3H. In some embodiments, R12 is SO3M1. In some embodiments, R12 is PO3H2. In some embodiments, R12 is PO3M12. In some embodiments, R12 is PO3M1H. In some embodiments, R12 is PO4H2. In some embodiments, R12 is PO4M12. In some embodiments, R12 is PO4M1H. In some embodiments, R12 is PO4M2. In some embodiments, R12 is C(O)NHOH. In some embodiments, R12 is NH2. In some embodiments, R12 is NHR. In some embodiments, R12 is N(R)2. In some embodiments, R12 is NO2. In some embodiments, R12 is COOR. In some embodiments, R12 is CHO. In some embodiments, R12 is CH2OH. In some embodiments, R12 is OH. In some embodiments, R12 is OR. In some embodiments, R12 is SH. In some embodiments, R12 is SR. In some embodiments, R12 is C(O)N(R)2. In some embodiments, R12 is C(O)NHR. In some embodiments, R12 is C(O)NH2. In some embodiments, R12 is halide. In some embodiments, R12 is tosylate. In some embodiments, R12 is mesylate. In some embodiments, R12 is SO2NHR. In some embodiments, R12 is triflate. In some embodiments, R12 is isocyanate. In some embodiments, R12 is cyanate. In some embodiments, R12 is thiocyanate. In some embodiments, R12 is isothiocyanate. In some embodiments, R12 is R. In some embodiments, R12 is cyano. In some embodiments, R12 is CF3. In some embodiments, R5 is Si(OR)3.
In some embodiments, R13 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R13 is CO2H. In some embodiments, R13 is CO2M1. In some embodiments, R13 is CO2R. In some embodiments, R13 is SO3H. In some embodiments, R13 is SO3M1. In some embodiments, R13 is PO3H2. In some embodiments, R13 is PO3M12. In some embodiments, R13 is PO3M1H. In some embodiments, R13 is PO4H2. In some embodiments, R13 is PO4M12. In some embodiments, R13 is PO4M1H. In some embodiments, R13 is PO4M2. In some embodiments, R13 is C(O)NHOH. In some embodiments, R13 is NH2. In some embodiments, R13 is NHR. In some embodiments, R13 is N(R)2. In some embodiments, R13 is NO2. In some embodiments, R13 is COOR. In some embodiments, R13 is CHO. In some embodiments, R13 is CH2OH. In some embodiments, R13 is OH. In some embodiments, R13 is OR. In some embodiments, R13 is SH. In some embodiments, R5 is SR. In some embodiments, R13 is C(O)N(R)2. In some embodiments, R13 is C(O)NHR. In some embodiments, R13 is C(O)NH2. In some embodiments, R13 is halide. In some embodiments, R13 is tosylate. In some embodiments, R13 is mesylate. In some embodiments, R13 is SO2NHR. In some embodiments, R13 is triflate. In some embodiments, R13 is isocyanate. In some embodiments, R13 is cyanate. In some embodiments, R13 is thiocyanate. In some embodiments, R13 is isothiocyanate. In some embodiments, R13 is R. In some embodiments, R13 is cyano. In some embodiments, R13 is CF3. In some embodiments, R13 is Si(OR)3.
In some embodiments, R14 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R14 is CO2H. In some embodiments, R14 is CO2M1. In some embodiments, R14 is CO2R. In some embodiments, R14 is SO3H. In some embodiments, R14 is SO3M1. In some embodiments, R14 is PO3H2. In some embodiments, R14 is PO3M12. In some embodiments, R14 is PO3M1H. In some embodiments, R14 is PO4H2. In some embodiments, R14 is PO4M12. In some embodiments, R14 is PO4M1H. In some embodiments, R14 is PO4M2. In some embodiments, R14 is C(O)NHOH. In some embodiments, R14 is NH2. In some embodiments, R14 is NHR. In some embodiments, R14 is N(R)2. In some embodiments, R14 is NO2. In some embodiments, R14 is COOR. In some embodiments, R14 is CHO. In some embodiments, R14 is CH2OH. In some embodiments, R14 is OH. In some embodiments, R14 is OR. In some embodiments, R14 is SH. In some embodiments, R14 is SR. In some embodiments, R14 is C(O)N(R)2. In some embodiments, R14 is C(O)NHR. In some embodiments, R14 is C(O)NH2. In some embodiments, R14 is halide. In some embodiments, R14 is tosylate. In some embodiments, R14 is mesylate. In some embodiments, R14 is SO2NHR. In some embodiments, R14 is triflate. In some embodiments, R14 is isocyanate. In some embodiments, R14 is cyanate. In some embodiments, R14 is thiocyanate. In some embodiments, R14 is isothiocyanate. In some embodiments, R14 is R. In some embodiments, R14 is cyano. In some embodiments, R14 is CF3. In some embodiments, R14 is Si(OR)3.
In some embodiments, R15 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R15 is CO2H. In some embodiments, R15 is CO2M1. In some embodiments, R15 is CO2R. In some embodiments, R15 is SO3H. In some embodiments, R15 is SO3M1. In some embodiments, R15 is PO3H2. In some embodiments, R15 is PO3M12. In some embodiments, R15 is PO3M1H. In some embodiments, R15 is PO4H2. In some embodiments, R15 is PO4M12. In some embodiments, R15 is PO4M1H. In some embodiments, R15 is PO4M2. In some embodiments, R15 is C(O)NHOH. In some embodiments, R15 is NH2. In some embodiments, R15 is NHR. In some embodiments, R15 is N(R)2. In some embodiments, R15 is NO2. In some embodiments, R15 is COOR. In some embodiments, R15 is CHO. In some embodiments, R15 is CH2OH. In some embodiments, R15 is OH. In some embodiments, R15 is OR. In some embodiments, R15 is SH. In some embodiments, R15 is SR. In some embodiments, R15 is C(O)N(R)2. In some embodiments, R15 is C(O)NHR. In some embodiments, R15 is C(O)NH2. In some embodiments, R15 is halide. In some embodiments, R15 is tosylate. In some embodiments, R15 is mesylate. In some embodiments, R15 is SO2NHR. In some embodiments, R15 is triflate. In some embodiments, R15 is isocyanate. In some embodiments, R15 is cyanate. In some embodiments, R15 is thiocyanate. In some embodiments, R15 is isothiocyanate. In some embodiments, R15 is R. In some embodiments, R15 is cyano. In some embodiments, R15 is CF3. In some embodiments, R15 is Si(OR)3.
In some embodiments, R16 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R16 is CO2H. In some embodiments, R16 is CO2M1. In some embodiments, R16 is CO2R. In some embodiments, R16 is SO3H. In some embodiments, R16 is SO3M1. In some embodiments, R16 is PO3H2. In some embodiments, R16 is PO3M12. In some embodiments, R16 is PO3M1H. In some embodiments, R16 is PO4H2. In some embodiments, R16 is PO4M12. In some embodiments, R16 is PO4M1H. In some embodiments, R16 is PO4M2. In some embodiments, R16 is C(O)NHOH. In some embodiments, R16 is NH2. In some embodiments, R16 is NHR. In some embodiments, R16 is N(R)2. In some embodiments, R16 is NO2. In some embodiments, R16 is COOR. In some embodiments, R16 is CHO. In some embodiments, R16 is CH2OH. In some embodiments, R16 is OH. In some embodiments, R16 is OR. In some embodiments, R16 is SH. In some embodiments, R16 is SR. In some embodiments, R16 is C(O)N(R)2. In some embodiments, R16 is C(O)NHR. In some embodiments, R16 is C(O)NH2. In some embodiments, R16 is halide. In some embodiments, R16 is tosylate. In some embodiments, R16 is mesylate. In some embodiments, R16 is SO2NHR. In some embodiments, R16 is triflate. In some embodiments, R16 is isocyanate. In some embodiments, R16 is cyanate. In some embodiments, R16 is thiocyanate. In some embodiments, R16 is isothiocyanate. In some embodiments, R16 is R. In some embodiments, R16 is cyano. In some embodiments, R16 is CF3. In some embodiments, R16 is Si(OR)3.
In some embodiments, R17 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R17 is CO2H. In some embodiments, R17 is CO2M1. In some embodiments, R17 is CO2R. In some embodiments, R17 is SO3H. In some embodiments, R17 is SO3M1. In some embodiments, R17 is PO3H2. In some embodiments, R17 is PO3M12. In some embodiments, R17 is PO3M1H. In some embodiments, R17 is PO4H2. In some embodiments, R17 is PO4M12. In some embodiments, R17 is PO4M1H. In some embodiments, R17 is PO4M2. In some embodiments, R17 is C(O)NHOH. In some embodiments, R17 is NH2. In some embodiments, R17 is NHR. In some embodiments, R17 is N(R)2. In some embodiments, R17 is NO2. In some embodiments, R17 is COOR. In some embodiments, R17 is CHO. In some embodiments, R17 is CH2OH. In some embodiments, R17 is OH. In some embodiments, R17 is OR. In some embodiments, R17 is SH. In some embodiments, R17 is SR. In some embodiments, R17 is C(O)N(R)2. In some embodiments, R17 is C(O)NHR. In some embodiments, R17 is C(O)NH2. In some embodiments, R17 is halide. In some embodiments, R17 is tosylate. In some embodiments, R17 is mesylate. In some embodiments, R17 is SO2NHR. In some embodiments, R17 is triflate. In some embodiments, R17 is isocyanate. In some embodiments, R17 is cyanate. In some embodiments, R17 is thiocyanate. In some embodiments, R17 is isothiocyanate. In some embodiments, R17 is R. In some embodiments, R17 is cyano. In some embodiments, R17 is CF3. In some embodiments, R17 is Si(OR)3.
In some embodiments, R18 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R18 is CO2H. In some embodiments, R18 is CO2M1. In some embodiments, R18 is CO2R. In some embodiments, R18 is SO3H. In some embodiments, R18 is SO3M1. In some embodiments, R18 is PO3H2. In some embodiments, R18 is PO3M12. In some embodiments, R18 is PO3M1H. In some embodiments, R18 is PO4H2. In some embodiments, R1-8 is PO4M12. In some embodiments, R18 is PO4M1H. In some embodiments, R18 is PO4M2. In some embodiments, R18 is C(O)NHOH. In some embodiments, R18 is NH2. In some embodiments, R18 is NHR. In some embodiments, R18 is N(R)2. In some embodiments, R18 is NO2. In some embodiments, R18 is COOR. In some embodiments, R18 is CHO. In some embodiments, R18 is CH2OH. In some embodiments, R18 is OH. In some embodiments, R18 is OR. In some embodiments, R13 is SH. In some embodiments, R18 is SR. In some embodiments, R18 is C(O)N(R)2. In some embodiments, R18 is C(O)NHR. In some embodiments, R18 is C(O)NH2. In some embodiments, R18 is halide. In some embodiments, R18 is tosylate. In some embodiments, R18 is mesylate. In some embodiments, R18 is SO2NHR. In some embodiments, R18 is triflate. In some embodiments, R18 is isocyanate. In some embodiments, R18 is cyanate. In some embodiments, R18 is thiocyanate. In some embodiments, R18 is isothiocyanate. In some embodiments, R18 is R. In some embodiments, R18 is cyano. In some embodiments, R18 is CF3. In some embodiments, R13 is Si(OR)3.
In some embodiments, R19 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R19 is CO2H. In some embodiments, R19 is CO2M1. In some embodiments, R19 is CO2R. In some embodiments, R19 is SO3H. In some embodiments, R19 is SO3M1. In some embodiments, R19 is PO3H2. In some embodiments, R19 is PO3M12. In some embodiments, R19 is PO3M1H. In some embodiments, R19 is PO4H2. In some embodiments, R19 is PO4M12. In some embodiments, R19 is PO4M1H. In some embodiments, R19 is PO4M2. In some embodiments, R19 is C(O)NHOH. In some embodiments, R19 is NH2. In some embodiments, R19 is NHR. In some embodiments, R19 is N(R)2. In some embodiments, R19 is NO2. In some embodiments, R19 is COOR. In some embodiments, R19 is CHO. In some embodiments, R19 is CH2OH. In some embodiments, R19 is OH. In some embodiments, R19 is OR. In some embodiments, R19 is SH. In some embodiments, R19 is SR. In some embodiments, R19 is C(O)N(R)2. In some embodiments, R19 is C(O)NHR. In some embodiments, R19 is C(O)NH2. In some embodiments, R19 is halide. In some embodiments, R19 is tosylate. In some embodiments, R19 is mesylate. In some embodiments, R19 is SO2NHR. In some embodiments, R19 is triflate. In some embodiments, R19 is isocyanate. In some embodiments, R19 is cyanate. In some embodiments, R19 is thiocyanate. In some embodiments, R19 is isothiocyanate. In some embodiments, R19 is R. In some embodiments, R19 is cyano. In some embodiments, R19 is CF3. In some embodiments, R19 is Si(OR)3.
In some embodiments, R20 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R20 is CO2H. In some embodiments, R20 is CO2M1. In some embodiments, R20 is CO2R. In some embodiments, R20 is SO3H. In some embodiments, R20 is SO3M1. In some embodiments, R20 is PO3H2. In some embodiments, R20 is PO3M12. In some embodiments, R20 is PO3M1H. In some embodiments, R20 is PO4H2. In some embodiments, R20 is PO4M12. In some embodiments, R20 is PO4M1H. In some embodiments, R20 is PO4M2. In some embodiments, R20 is C(O)NHOH. In some embodiments, R20 is NH2. In some embodiments, R20 is NHR. In some embodiments, R20 is N(R)2. In some embodiments, R20 is NO2. In some embodiments, R20 is COOR. In some embodiments, R20 is CHO. In some embodiments, R20 is CH2OH. In some embodiments, R20 is OH. In some embodiments, R20 is OR. In some embodiments, R13 is SH. In some embodiments, R20 is SR. In some embodiments, R20 is C(O)N(R)2. In some embodiments, R20 is C(O)NHR. In some embodiments, R20 is C(O)NH2. In some embodiments, R20 is halide. In some embodiments, R20 is tosylate. In some embodiments, R20 is mesylate. In some embodiments, R20 is SO2NHR. In some embodiments, R20 is triflate. In some embodiments, R20 is isocyanate. In some embodiments, R20 is cyanate. In some embodiments, R20 is thiocyanate. In some embodiments, R20 is isothiocyanate. In some embodiments, R20 is R. In some embodiments, R20 is cyano. In some embodiments, R20 is CF3. In some embodiments, R20 is Si(OR)3.
In some embodiments, R21 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R21 is CO2H. In some embodiments, R21 is CO2M1. In some embodiments, R21 is CO2R. In some embodiments, R21 is SO3H. In some embodiments, R21 is SO3M1. In some embodiments, R21 is PO3H2. In some embodiments, R21 is PO3M12. In some embodiments, R21 is PO3M1H. In some embodiments, R21 is PO4H2. In some embodiments, R21 is PO4M12. In some embodiments, R21 is PO4M1H. In some embodiments, R21 is PO4M2. In some embodiments, R21 is C(O)NHOH. In some embodiments, R21 is NH2. In some embodiments, R21 is NHR. In some embodiments, R21 is N(R)2. In some embodiments, R21 is NO2. In some embodiments, R21 is COOR. In some embodiments, R21 is CHO. In some embodiments, R21 is CH2OH. In some embodiments, R21 is OH. In some embodiments, R21 is OR. In some embodiments, R13 is SH. In some embodiments, R21 is SR. In some embodiments, R21 is C(O)N(R)2. In some embodiments, R21 is C(O)NHR. In some embodiments, R21 is C(O)NH2. In some embodiments, R21 is halide. In some embodiments, R21 is tosylate. In some embodiments, R21 is mesylate. In some embodiments, R21 is SO2NHR. In some embodiments, R21 is triflate. In some embodiments, R21 is isocyanate. In some embodiments, R21 is cyanate. In some embodiments, R21 is thiocyanate. In some embodiments, R21 is isothiocyanate. In some embodiments, R21 is R. In some embodiments, R21 is cyano. In some embodiments, R21 is CF3. In some embodiments, R21 is Si(OR)3.
In some embodiments, R22 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R22 is CO2H. In some embodiments, R22 is CO2M1. In some embodiments, R22 is CO2R. In some embodiments, R22 is SO3H. In some embodiments, R22 is SO3M1. In some embodiments, R22 is PO3H2. In some embodiments, R22 is PO3M12. In some embodiments, R22 is PO3M1H. In some embodiments, R22 is PO4H2. In some embodiments, R22 is PO4M12. In some embodiments, R22 is PO4M1H. In some embodiments, R22 is PO4M2. In some embodiments, R22 is C(O)NHOH. In some embodiments, R22 is NH2. In some embodiments, R22 is NHR. In some embodiments, R22 is N(R)2. In some embodiments, R22 is NO2. In some embodiments, R22 is COOR. In some embodiments, R22 is CHO. In some embodiments, R22 is CH2OH. In some embodiments, R22 is OH. In some embodiments, R22 is OR. In some embodiments, R22 is SH. In some embodiments, R22 is SR. In some embodiments, R22 is C(O)N(R)2. In some embodiments, R22 is C(O)NHR. In some embodiments, R22 is C(O)NH2. In some embodiments, R22 is halide. In some embodiments, R22 is tosylate. In some embodiments, R22 is mesylate. In some embodiments, R22 is SO2NHR. In some embodiments, R22 is triflate. In some embodiments, R22 is isocyanate. In some embodiments, R22 is cyanate. In some embodiments, R22 is thiocyanate. In some embodiments, R22 is isothiocyanate. In some embodiments, R22 is R. In some embodiments, R22 is cyano. In some embodiments, R22 is CF3. In some embodiments, R22 is Si(OR)3.
In some embodiments, R101 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R101 is CO2H. In some embodiments, R101 is CO2M1. In some embodiments, R101 is CO2R. In some embodiments, R101 is SO3H. In some embodiments, R101 is SO3M1. In some embodiments, R101 is PO3H2. In some embodiments, R101 is PO3M12. In some embodiments, R101 is PO3M1H. In some embodiments, R101 is PO4H2. In some embodiments, R101 is PO4M12. In some embodiments, R101 is PO4M1H. In some embodiments, R101 is PO4M2. In some embodiments, R101 is C(O)NHOH. In some embodiments, R101 is NH2. In some embodiments, R101 is NHR. In some embodiments, R101 is N(R)2. In some embodiments, R101 is NO2. In some embodiments, R101 is COOR. In some embodiments, R101 is CHO. In some embodiments, R101 is CH2OH. In some embodiments, R101 is OH. In some embodiments, R101 is OR. In some embodiments, R101 is SH. In some embodiments, R101 is SR. In some embodiments, R101 is C(O)N(R)2. In some embodiments, R101 is C(O)NHR. In some embodiments, R101 is C(O)NH2. In some embodiments, R101 is halide. In some embodiments, R101 is tosylate. In some embodiments, R101 is mesylate. In some embodiments, R101 is SO2NHR. In some embodiments, R101 is triflate. In some embodiments, R101 is isocyanate. In some embodiments, R101 is cyanate. In some embodiments, R101 is thiocyanate. In some embodiments, R101 is isothiocyanate. In some embodiments, R101 is R. In some embodiments, R101 is cyano. In some embodiments, R101 is CF3. In some embodiments, R101 is Si(OR)3.
In some embodiments, R102 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R102 is CO2H. In some embodiments, R102 is CO2M1. In some embodiments, R102 is CO2R. In some embodiments, R102 is SO3H. In some embodiments, R102 is SO3M1. In some embodiments, R102 is PO3H2. In some embodiments, R102 is PO3M12. In some embodiments, R102 is PO3M1H. In some embodiments, R102 is PO4H2. In some embodiments, R102 is PO4M12. In some embodiments, R102 is PO4M1H. In some embodiments, R102 is PO4M2. In some embodiments, R102 is C(O)NHOH. In some embodiments, R102 is NH2. In some embodiments, R102 is NHR. In some embodiments, R102 is N(R)2. In some embodiments, R102 is NO2. In some embodiments, R102 is COOR. In some embodiments, R102 is CHO. In some embodiments, R102 is CH2OH. In some embodiments, R102 is OH. In some embodiments, R102 is OR. In some embodiments, R102 is SH. In some embodiments, R102 is SR. In some embodiments, R102 is C(O)N(R)2. In some embodiments, R102 is C(O)NHR. In some embodiments, R102 is C(O)NH2. In some embodiments, R102 is halide. In some embodiments, R102 is tosylate. In some embodiments, R102 is mesylate. In some embodiments, R102 is SO2NHR. In some embodiments, R102 is triflate. In some embodiments, R102 is isocyanate. In some embodiments, R102 is cyanate. In some embodiments, R102 is thiocyanate. In some embodiments, R102 is isothiocyanate. In some embodiments, R102 is R. In some embodiments, R102 is cyano. In some embodiments, R102 is CF3. In some embodiments, R102 is Si(OR)3.
In some embodiments, R104 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R104 is CO2H. In some embodiments, R104 is CO2M1. In some embodiments, R104 is CO2R. In some embodiments, R104 is SO3H. In some embodiments, R104 is SO3M1. In some embodiments, R104 is PO3H2. In some embodiments, R104 is PO3M12. In some embodiments, R104 is PO3M1H. In some embodiments, R104 is PO4H2. In some embodiments, R104 is PO4M12. In some embodiments, R104 is PO4M1H. In some embodiments, R104 is PO4M2. In some embodiments, R104 is C(O)NHOH. In some embodiments, R104 is NH2. In some embodiments, R104 is NHR. In some embodiments, R104 is N(R)2. In some embodiments, R104 is NO2. In some embodiments, R104 is COOR. In some embodiments, R104 is CHO. In some embodiments, R104 is CH2OH. In some embodiments, R104 is OH. In some embodiments, R104 is OR. In some embodiments, R104 is SH. In some embodiments, R104 is SR. In some embodiments, R104 is C(O)N(R)2. In some embodiments, R104 is C(O)NHR. In some embodiments, R104 is C(O)NH2. In some embodiments, R104 is halide. In some embodiments, R104 is tosylate. In some embodiments, R104 is mesylate. In some embodiments, R104 is SO2NHR. In some embodiments, R104 is triflate. In some embodiments, R104 is isocyanate. In some embodiments, R104 is cyanate. In some embodiments, R104 is thiocyanate. In some embodiments, R104 is isothiocyanate. In some embodiments, R104 is R. In some embodiments, R104 is cyano. In some embodiments, R104 is CF3. In some embodiments, R104 is Si(OR)3.
In some embodiments, R105 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R105 is CO2H. In some embodiments, R105 is CO2M1. In some embodiments, R105 is CO2R. In some embodiments, R105 is SO3H. In some embodiments, R105 is SO3M1. In some embodiments, R105 is PO3H2. In some embodiments, R105 is PO3M12. In some embodiments, R105 is PO3M1H. In some embodiments, R105 is PO4H2. In some embodiments, R105 is PO4M12. In some embodiments, R105 is PO4M1H. In some embodiments, R105 is PO4M2. In some embodiments, R105 is C(O)NHOH. In some embodiments, R105 is NH2. In some embodiments, R105 is NHR. In some embodiments, R105 is N(R)2. In some embodiments, R105 is NO2. In some embodiments, R105 is COOR. In some embodiments, R105 is CHO. In some embodiments, R105 is CH2OH. In some embodiments, R105 is OH. In some embodiments, R105 is OR. In some embodiments, R105 is SH. In some embodiments, R105 is SR. In some embodiments, R105 is C(O)N(R)2. In some embodiments, R105 is C(O)NHR. In some embodiments, R105 is C(O)NH2. In some embodiments, R105 is halide. In some embodiments, R105 is tosylate. In some embodiments, R105 is mesylate. In some embodiments, R105 is SO2NHR. In some embodiments, R105 is triflate. In some embodiments, R105 is isocyanate. In some embodiments, R105 is cyanate. In some embodiments, R105 is thiocyanate. In some embodiments, R105 is isothiocyanate. In some embodiments, R105 is R. In some embodiments, R105 is cyano. In some embodiments, R105 is CF3. In some embodiments, R105 is Si(OR)3.
In some embodiments, R106 is CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, R106 is CO2H. In some embodiments, R106 is CO2M1. In some embodiments, R106 is CO2R. In some embodiments, R106 is SO3H. In some embodiments, R106 is SO3M1. In some embodiments, R106 is PO3H2. In some embodiments, R106 is PO3M12. In some embodiments, R106 is PO3M1H. In some embodiments, R106 is PO4H2. In some embodiments, R106 is PO4M12. In some embodiments, R106 is PO4M1H. In some embodiments, R106 is PO4M2. In some embodiments, R106 is C(O)NHOH. In some embodiments, R106 is NH2. In some embodiments, R106 is NHR. In some embodiments, R106 is N(R)2. In some embodiments, R106 is NO2. In some embodiments, R106 is COOR. In some embodiments, R106 is CHO. In some embodiments, R106 is CH2OH. In some embodiments, R106 is OH. In some embodiments, R106 is OR. In some embodiments, R106 is SH. In some embodiments, R106 is SR. In some embodiments, R106 is C(O)N(R)2. In some embodiments, R106 is C(O)NHR. In some embodiments, R106 is C(O)NH2. In some embodiments, R106 is halide. In some embodiments, R106 is tosylate. In some embodiments, R106 is mesylate. In some embodiments, R106 is SO2NHR. In some embodiments, R106 is triflate. In some embodiments, R106 is isocyanate. In some embodiments, R106 is cyanate. In some embodiments, R106 is thiocyanate. In some embodiments, R106 is isothiocyanate. In some embodiments, R106 is R. In some embodiments, R106 is cyano. In some embodiments, R106 is CF3. In some embodiments, R106 is Si(OR)3.
In some embodiments, T1 is H, CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, T2 is H. In some embodiments, T1 is CO2H. In some embodiments, T1 is CO2M1. In some embodiments, T1 is CO2R. In some embodiments, T1 is SO3H. In some embodiments, T1 is SO3M1. In some embodiments, T1 is PO3H2. In some embodiments, T1 is PO3M12. In some embodiments, T1 is PO3M1H. In some embodiments, T1 is PO4H2. In some embodiments, T1 is PO4M12. In some embodiments, T1 is PO4M1H. In some embodiments, T1 is PO4M2. In some embodiments, T1 is C(O)NHOH. In some embodiments, T1 is NH2. In some embodiments, T1 is NHR. In some embodiments, T1 is N(R)2. In some embodiments, T1 is NO2. In some embodiments, T1 is COOR. In some embodiments, T1 is CHO. In some embodiments, T1 is CH2OH. In some embodiments, T1 is OH. In some embodiments, T1 is OR. In some embodiments, T1 is SH. In some embodiments, T1 is SR. In some embodiments, T1 is C(O)N(R)2. In some embodiments, T1 is C(O)NHR. In some embodiments, T1 is C(O)NH2. In some embodiments, T1 is halide. In some embodiments, T1 is tosylate. In some embodiments, T1 is mesylate. In some embodiments, T1 is SO2NHR. In some embodiments, T1 is triflate. In some embodiments, T1 is isocyanate. In some embodiments, T1 is cyanate. In some embodiments, T1 is thiocyanate. In some embodiments, T1 is isothiocyanate. In some embodiments, T1 is R. In some embodiments, T1 is cyano. In some embodiments, T1 is CF3. In some embodiments, T1 is Si(OR)3.
In some embodiments, T2 is H, CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12. PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, T2 is H. In some embodiments, T2 is CO2H. In some embodiments, T2 is CO2M1. In some embodiments, T2 is CO2R. In some embodiments, T2 is SO3H. In some embodiments, T2 is SO3M1. In some embodiments, T2 is PO3H2. In some embodiments, T2 is PO3M12. In some embodiments, T2 is PO3M1H. In some embodiments, T2 is PO4H2. In some embodiments, T2 is PO4M12. In some embodiments, T2 is PO4M1H. In some embodiments, T2 is PO4M2. In some embodiments, T2 is C(O)NHOH. In some embodiments, T2 is NH2. In some embodiments, T2 is NHR. In some embodiments, T2 is N(R)2. In some embodiments, T2 is NO2. In some embodiments, T2 is COOR. In some embodiments, T2 is CHO. In some embodiments, T2 is CH2OH. In some embodiments, T2 is OH. In some embodiments, T2 is OR. In some embodiments, T2 is SH. In some embodiments, T2 is SR. In some embodiments, T2 is C(O)N(R)2. In some embodiments, T2 is C(O)NHR. In some embodiments, T2 is C(O)NH2. In some embodiments, T2 is halide. In some embodiments, T2 is tosylate. In some embodiments, T2 is mesylate. In some embodiments, T2 is SO2NHR. In some embodiments, T2 is triflate. In some embodiments, T2 is isocyanate. In some embodiments, T2 is cyanate. In some embodiments, T2 is thiocyanate. In some embodiments, T2 is isothiocyanate. In some embodiments, T2 is R. In some embodiments, T2 is cyano. In some embodiments, T2 is CF3. In some embodiments, T2 is Si(OR)3.
In some embodiments, T3 is H, CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12, PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, T3 is H. In some embodiments, T3 is CO2H. In some embodiments, T3 is CO2M1. In some embodiments, T3 is CO2R. In some embodiments, T3 is SO3H. In some embodiments, T3 is SO3M1. In some embodiments, T3 is PO3H2. In some embodiments, T3 is PO3M12. In some embodiments, T3 is PO3M1H. In some embodiments, T3 is PO4H2. In some embodiments, T3 is PO4M12. In some embodiments, T3 is PO4M1H. In some embodiments, T3 is PO4M2. In some embodiments, T3 is C(O)NHOH. In some embodiments, T3 is NH2. In some embodiments, T3 is NHR. In some embodiments, T3 is N(R)2. In some embodiments, T3 is NO2. In some embodiments, T3 is COOR. In some embodiments, T3 is CHO. In some embodiments, T3 is CH2OH. In some embodiments, T3 is OH. In some embodiments, T3 is OR. In some embodiments, T3 is SH. In some embodiments, T3 is SR. In some embodiments, T3 is C(O)N(R)2. In some embodiments, T3 is C(O)NHR. In some embodiments, T3 is C(O)NH2. In some embodiments, T3 is halide. In some embodiments, T3 is tosylate. In some embodiments, T3 is mesylate. In some embodiments, T3 is SO2NHR. In some embodiments, T3 is triflate. In some embodiments, T3 is isocyanate. In some embodiments, T3 is cyanate. In some embodiments, T3 is thiocyanate. In some embodiments, T3 is isothiocyanate. In some embodiments, T3 is R. In some embodiments, T3 is cyano. In some embodiments, T3 is CF3. In some embodiments, T3 is Si(OR)3.
In some embodiments, T4 is H, CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12, PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, T4 is H. In some embodiments, T4 is CO2H. In some embodiments, T4 is CO2M1. In some embodiments, T4 is CO2R. In some embodiments, T4 is SO3H. In some embodiments, T4 is SO3M1. In some embodiments, T4 is PO3H2. In some embodiments, T4 is PO3M12. In some embodiments, T4 is PO3M1H. In some embodiments, T4 is PO4H2. In some embodiments, T4 is PO4M12. In some embodiments, T4 is PO4M1H. In some embodiments, T4 is PO4M2. In some embodiments, T4 is C(O)NHOH. In some embodiments, T4 is NH2. In some embodiments, T4 is NHR. In some embodiments, T4 is N(R)2. In some embodiments, T4 is NO2. In some embodiments, T4 is COOR. In some embodiments, T4 is CHO. In some embodiments, T4 is CH2OH. In some embodiments, T4 is OH. In some embodiments, T4 is OR. In some embodiments, T3 is SH. In some embodiments, T4 is SR. In some embodiments, T4 is C(O)N(R)2. In some embodiments, T4 is C(O)NHR. In some embodiments, T4 is C(O)NH2. In some embodiments, T4 is halide. In some embodiments, T4 is tosylate. In some embodiments, T4 is mesylate. In some embodiments, T4 is SO2NHR. In some embodiments, T4 is triflate. In some embodiments, T4 is isocyanate. In some embodiments, T4 is cyanate. In some embodiments, T4 is thiocyanate. In some embodiments, T4 is isothiocyanate. In some embodiments, T4 is R. In some embodiments, T4 is cyano. In some embodiments, T4 is CF3. In some embodiments, T4 is Si(OR)3.
In some embodiments, T5 is H, CO2H, CO2M1, CO2R, SO3H, SO3H, SO3M1, PO3H2, PO3M12, PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, T5 is H. In some embodiments, T5 is CO2H. In some embodiments, T5 is CO2M1. In some embodiments, T5 is CO2R. In some embodiments, T5 is SO3H. In some embodiments, T5 is SO3M1. In some embodiments, T5 is PO3H2. In some embodiments, T5 is PO3M12. In some embodiments, T5 is PO3M1H. In some embodiments, T5 is PO4H2. In some embodiments, T5 is PO4M12. In some embodiments, T5 is PO4M1H. In some embodiments, T5 is PO4M2. In some embodiments, T5 is C(O)NHOH. In some embodiments, T5 is NH2. In some embodiments, T5 is NHR. In some embodiments, T5 is N(R)2. In some embodiments, T5 is NO2. In some embodiments, T5 is COOR. In some embodiments, T5 is CHO. In some embodiments, T5 is CH2OH. In some embodiments, T5 is OH. In some embodiments, T5 is OR. In some embodiments, T5 is SH. In some embodiments, T5 is SR. In some embodiments, T5 is C(O)N(R)2. In some embodiments, T5 is C(O)NHR. In some embodiments, T5 is C(O)NH2. In some embodiments, T5 is halide. In some embodiments, T5 is tosylate. In some embodiments, T5 is mesylate. In some embodiments, T5 is SO2NHR. In some embodiments, T5 is triflate. In some embodiments, T5 is isocyanate. In some embodiments, T5 is cyanate. In some embodiments, T5 is thiocyanate. In some embodiments, T5 is isothiocyanate. In some embodiments, T5 is R. In some embodiments, T5 is cyano. In some embodiments, T5 is CF3. In some embodiments, T5 is Si(OR)3.
In some embodiments, T6 is H, CO2H, CO2M1, CO2R, SO3H, SO3M1, PO3H2, PO3M12, PO3M1H, PO4H2, PO4M12, PO4M1H, PO4M2, C(O)NHOH, NH2, NHR, N(R)2, NO2, COOR, CHO, CH2OH, OH, OR, SH, SR, C(O)N(R)2, C(O)NHR, C(O)NH2, halide, tosylate, mesylate, SO2NHR, triflate, isocyanate, cyanate, thiocyanate, isothiocyanate, R, cyano CF3 or Si(OR)3. In some embodiments, T6 is H. In some embodiments, T6 is CO2H. In some embodiments, T6 is CO2M1. In some embodiments, T6 is CO2R. In some embodiments, T6 is SO3H. In some embodiments, T6 is SO3M1. In some embodiments, T6 is PO3H2. In some embodiments, T6 is PO3M12. In some embodiments, T6 is PO3M1H. In some embodiments, T6 is PO4H2. In some embodiments, T6 is PO4M12. In some embodiments, T6 is PO4M1H. In some embodiments, T6 is PO4M2. In some embodiments, T6 is C(O)NHOH. In some embodiments, T6 is NH2. In some embodiments, T6 is NHR. In some embodiments, T6 is N(R)2. In some embodiments, T6 is NO2. In some embodiments, T6 is COOR. In some embodiments, T6 is CHO. In some embodiments, T6 is CH2OH. In some embodiments, T6 is OH. In some embodiments, T6 is OR. In some embodiments, T6 is SH. In some embodiments, T6 is SR. In some embodiments, T6 is C(O)N(R)2. In some embodiments, T6 is C(O)NHR. In some embodiments, T6 is C(O)NH2. In some embodiments, T6 is halide. In some embodiments, T6 is tosylate. In some embodiments, T6 is mesylate. In some embodiments, T6 is SO2NHR. In some embodiments, T6 is triflate. In some embodiments, T6 is isocyanate. In some embodiments, T6 is cyanate. In some embodiments, T6 is thiocyanate. In some embodiments, T6 is isothiocyanate. In some embodiments, T6 is R. In some embodiments, T6 is cyano. In some embodiments, T6 is CF3. In some embodiments, T6 is Si(OR)3.
In some embodiments, R is methyl, ethyl, isopropyl, n-propyl, alkyl, haloalkyl, cycloalkyl, heterocycloalkyl, aryl, or benzyl. In some embodiments, R is methyl. In some embodiments, R is ethyl. In some embodiments, R is isopropyl. In some embodiments, R is n-propyl. In some embodiments, R is alkyl. In some embodiments, R is haloalkyl. In some embodiments, R is cycloalkyl. In some embodiments, R is heterocycloalkyl. In some embodiments, R is aryl. In some embodiments, R is benzyl.
In some embodiments, M1 is selected from any alkali metal. In some embodiments, M1 is Li, Na, K, Rb or Cs. In some embodiments, M1 is Li. In some embodiments, M1 is Na. In some embodiments, M1 is K. In some embodiments, M1 is Rb. In some embodiments, M1 is Cs.
In some embodiments, M2 is selected from any alkaline earth metal. In some embodiments, M1 is Be, Mg, Ca, Sr, Ba or Ra. In some embodiments, M1 is Be. In some embodiments, M1 is Mg. In some embodiments, M1 is Ca. In some embodiments, M1 is Sr. In some embodiments, M1 is Ba. In some embodiments, M1 is Ra.
An “alkyl” group refers, in some embodiments, to a saturated aliphatic hydrocarbon, including straight-chain or branched-chain. In some embodiments, alkyl is linear or branched. In some embodiments, alkyl is optionally substituted linear or branched. In some embodiments, alkyl is methyl. In some embodiments alkyl is ethyl. In some embodiments, the alkyl group has 1-20 carbons. In some embodiments, the alkyl group has 1-8 carbons. In some embodiments, the alkyl group has 1-7 carbons. In some embodiments, the alkyl group has 1-6 carbons. In some embodiments, non-limiting examples of alkyl groups include methyl, ethyl, isopropyl, n-propyl, isobutyl, butyl, pentyl or hexyl. In some embodiments, the alkyl group has 1-4 carbons. In some embodiments, the alkyl group may be optionally substituted by one or more groups selected from halide, hydroxy, alkoxy, carboxylic acid, aldehyde, carbonyl, amido, cyano, nitro, amino, alkenyl, alkynyl, aryl, azide, epoxide, ester, acyl chloride and thiol.
A “cycloalkyl” group refers, in some embodiments, to a ring structure comprising carbon atoms as ring atoms, which are saturated, substituted or unsubstituted. In some embodiments the cycloalkyl is a 3-12 membered ring. In some embodiments the cycloalkyl is a 6 membered ring. In some embodiments the cycloalkyl is a 5-7 membered ring. In some embodiments the cycloalkyl is a 3-8 membered ring. In some embodiments, the cycloalkyl group may be unsubstituted or substituted by a halogen, alkyl, haloalkyl, hydroxyl, alkoxy, carbonyl, amido, alkylamido, dialkylamido, cyano, nitro, CO2H, amino, alkylamino, dialkylamino, carboxyl, thio and/or thioalkyl. In some embodiments, the cycloalkyl ring may be fused to another saturated or unsaturated 3-8 membered ring. In some embodiments, the cycloalkyl ring is an unsaturated ring. Non limiting examples of a cycloalkyl group comprise cyclohexyl, cyclohexenyl, cyclopropyl, cyclopropenyl, cyclopentyl, cyclopentenyl, cyclobutyl, cyclobutenyl, cycloctyl, cycloctadienyl (COD), cycloctaene (COE) etc.
A “heterocycloalkyl” group refers in some embodiments, to a ring structure of a cycloalkyl as described herein comprising in addition to carbon atoms, sulfur, oxygen, nitrogen or any combination thereof, as part of the ring. In some embodiments, non-limiting examples of heterocycloalkyl include pyrrolidine, pyrrole, tetrahydrofuran, furan, thiolane, thiophene, imidazole, pyrazole, pyrazolidine, oxazolidine, oxazole, isoxazole, thiazole, isothiazole, thiazolidine, dioxolane, dithiolane, triazole, furazan, oxadiazole, thiadiazole, dithiazole, tetrazole, piperidine, oxane, thiane, pyridine, pyran, thiopyran, piperazine, morpholine, thiomorpholine, dioxane, dithiane, diazine, oxazine, thiazine, dioxine, triazine, and trioxane.
A “crown etheryl” group refers in some embodiments to a cyclic structure that comprises several ether groups. In some embodiments, the cyclic structure comprises a —CH2CH2O— repeating unit. In some embodiments, the cyclic structure optionally comprises a —CH2CH2NH— repeating unit. In some embodiments, non-limiting examples of the cyclic structure has between 4-10 repeating units. In some embodiments, the cyclic structure is substituted. Substitutions include but are not limited to: F, Cl, Br, I, C1-C5 linear or branched alkyl, C1-C5 linear or branched haloalkyl, C1-C5 linear or branched alkoxy, C1-C5 linear or branched haloalkoxy, CF3, CN, NO2, —CH2CN, NH2, NH-alkyl, N(alkyl)2, hydroxyl, —OC(O)CF3, —OCH2Ph, —NHCO-alkyl, COOH, —C(O)Ph, C(O)O-alkyl, C(O)H, or - or —C(O)NH2.
A cyclamyl, cyclenyl, 1,4,7-Triazacyclononanyl, hexacyclenyl, groups refer in some embodiment to cyclic structures that comprise several repeating units that contain alkylamino groups. In some other embodiments, the cyclic structures are substituted. Substitutions include but are not limited to: F, Cl, Br, I, C1-C5 linear or branched alkyl, C1-C5 linear or branched haloalkyl, C1-C5 linear or branched alkoxy, C1-C5 linear or branched haloalkoxy, CF3, CN, NO2, —CH2CN, NH2, NH-alkyl, N(alkyl)2, hydroxyl, —OC(O)CF3, —OCH2Ph, —NHCO-alkyl, COOH, —C(O)Ph, C(O)O-alkyl, C(O)H, or - or —C(O)NH2.
A “cryptandyl” group refers in some embodiments to a three dimensional structure that comprises several ether and alkylamino groups. In some embodiments, the structure is a [2.2.2]Cryptand: N[CH2CH2OCH2CH2OCH2CH2]3N (1,10-diaza-4,7,13,16,21,24-hexaoxabicyclo[8.8.8]hexacosane). In some embodiments, the cyclic structure is substituted. Substitutions include but are not limited to: F, Cl, Br, I, C1-C5 linear or branched alkyl, C1-C5 linear or branched haloalkyl, C1-C5 linear or branched alkoxy, C1-C5 linear or branched haloalkoxy, CF3, CN, NO2, —CH2CN, NH2, NH-alkyl, N(alkyl)2, hydroxyl, —OC(O)CF3, —OCH2Ph, —NHCO-alkyl, COOH, —C(O)Ph, C(O)O-alkyl, C(O)H, or - or —C(O)NH2.
As used herein, the term “aryl” refers to any aromatic ring that is directly bonded to another group and can be either substituted or unsubstituted. The aryl group can be a sole substituent, or the aryl group can be a component of a larger substituent, such as in an arylalkyl, arylamino, arylamido, etc. Exemplary aryl groups include, without limitation, phenyl, tolyl, xylyl, furanyl, naphthyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, thiazolyl, oxazolyl, isooxazolyl, pyrazolyl, imidazolyl, thiophene-yl, pyrrolyl, phenylmethyl, phenylethyl, phenylamino, phenylamido, etc. Substitutions include but are not limited to: F, Cl, Br, I, C1-C5 linear or branched alkyl, C1-C5 linear or branched haloalkyl, C1-C5 linear or branched alkoxy, C1-C5 linear or branched haloalkoxy, CF3, CN, NO2, —CH2CN, NH2, NH-alkyl, N(alkyl)2, hydroxyl, —OC(O)CF3, —OCH2Ph, —NHCO-alkyl, COOH, —C(O)Ph, C(O)O-alkyl, C(O)H, or - or —C(O)NH2.
In some embodiments, the term “halide” used herein refers to any substituent of the halogen group (group 17). In some embodiments, halide is flouride, chloride, bromide or iodide. In some embodiments, halide is fluoride. In some embodiments, halide is chloride. In some embodiments, halide is bromide. In some embodiments, halide is iodide.
In some embodiments, “haloalkyl” refers to alkyl, alkenyl, alkynyl or cycloalkyl substituted with one or more halide atoms. In some embodiments, haloalkyl is partially halogenated. In some embodiments haloalkyl is perhalogenated (completely halogenated, no C—H bonds). In some embodiments, haloalkyl is CH2CF3. In some embodiments, haloalkyl is CH2CCl3. In some embodiments, haloalkyl is CH2CBr3. In some embodiments, haloalkyl is CH2CI3. In some embodiments, haloalkyl is CF2CF3. In some embodiments, haloalkyl is CH2CH2CF3. In some embodiments, haloalkyl is CH2CF2CF3. In some embodiments, haloalkyl is CF2CF2CF3. In some embodiments, the haloalkyl group may be optionally substituted by one or more groups selected from halide, hydroxy, alkoxy, carboxylic acid, aldehyde, carbonyl, amido, cyano, nitro, amino, alkenyl, alkynyl, aryl, azide, epoxide, ester, acyl chloride and thiol.
In some embodiments, the term “benzyl” used herein refers to a methylene (CH2, CHR or CR2) connected to an “aryl” (described above) moiety. In some embodiments, the methylene is non substituted (CH2). In some embodiments, the methylene is substituted (CHR or CR2). In some embodiments, the methylene is substituted with alkyl, haloalkyl, cycloalkyl, heterocycloalkyl, aryl, benzyl or any combination of such moieties.
In some embodiments, X1 is S, O or CH2. In some embodiments, X1 is S. In some embodiments, X1 is O. In some embodiments, X1 is CH2.
In some embodiments, X2 is S, O or CH2. In some embodiments, X2 is S. In some embodiments, X2 is O. In some embodiments, X2 is CH2.
In some embodiments, X3 is S, O or CH2. In some embodiments, X3 is S. In some embodiments, X3 is O. In some embodiments, X3 is CH2.
In some embodiments, X4 is S, O or CH2. In some embodiments, X4 is S. In some embodiments, X4 is O. In some embodiments, X4 is CH2.
For example, various coatings of the anode active material may be used to bond or enhance bonding of molecules 116 to anode material 110, as disclosed above. The size(s) of molecules 116 may be selected to provide good lithium ion conductivity therethrough. In certain embodiments, molecules 116 may be selected (e.g., some of the disclosed salts) to form channels configured to enable fast lithium ion movement therethrough.
Surface molecules layer 117 may be configured to prevent contact of electrolyte solvent (of electrolyte 85) with anode active material 110, e.g., through steric hindrance by molecules 116. Non-limiting examples are embodiments represented e.g., by formulas II, IV and V, among others, such as the non-limiting examples lithium 3,5-dicarboxybenzenesulfonate, lithium 2,6-di-tert-butylbenzene-1,4-disulfonate, 3,3′-((1,2-dithiane-4,5-diyl)bis(oxy))bis(N-hydroxypropanamide), 3,3′-((4-mercapto-1,2-phenylene)bis(oxy))bis(N-hydroxypropanamide), etc.
Molecules 116 may be selected and attached onto anode active material 110 in a way that forms a mechanical and/or electrostatic barrier towards electrolyte solvent and prevents it from reaching and interacting with anode active material 110. Bonding molecules 116 may be selected to have electron rich groups that provide mobile electric charge on the surface of molecules layer 117. Non-limiting examples are embodiments represented e.g., by formulas II, and IV-VII, having conjugated double bonds, acidic groups and benzene groups, among others, such as the non-limiting examples lithium 4-methylbenzenesulfonate, lithium 3,5-dicarboxybenzene sulfonate, lithium 2,6-dimethylbenzene-1,4-disulfonate, 3,3′-((1,2-dithiane-4,5-diyl)bis(oxy))bis(N-hydroxypropanamide), 3,3′-((4-mercapto-1,2-phenylene)bis(oxy))bis(N-hydroxypropanamide), lithium aniline sulfonate, poly(lithium-4-styrenesulfonate) etc.
For example, bonding molecules 116 may be selected to have a width W (anchored in anode 100 and/or anode active material particles 110) of up to three benzene rings and a length L (protruding into electrolyte 105) of up to four benzene rings, as exemplified in a non-limiting manner in embodiments represented e.g., by formulas II and VII having bicyclic or tricyclic structures, e.g., anthracene-based structures and/or in embodiments represented e.g., by formulas IV and V.
In some embodiments, bonding molecules 116 may comprise an anode material anchoring part 116A, configured to bind to or be associated with anode active material 110, e.g., via lithium, thiols, or other functional groups in bonding molecules 116. In some embodiments, anode material anchoring part 116A may be pre-lithiated exemplified in a non-limiting manner in embodiments represented by any of formulas I-VII which include lithium, such as the non-limiting examples illustrated in
In some embodiments, bonding molecules 116 may comprise an ionic conductive part 116B having an ionic conductivity which is much higher than its electronic conductivity, e.g., by one, two, three or more orders of magnitude. Ionic conductive part 116B may extend through most or all of length L of bonding molecules 116 and provide a conductivity path 91A (illustrated schematically) for lithium ions 91 moving back and forth between electrolyte 105 and anode 110 during charging and discharging cycles. Conductivity paths 91A may be provided e.g., by conjugated double bonds, acidic groups, benzene rings, carbon-fluorine bonds, charged functional groups etc. which are disclosed above. For example, the charge distribution on bonding molecules 116 may be selected to be mobile and support lithium ion movement across molecules layer 117, possibly reducing the charge of the lithium ion to Liδ+ as explained above, to prevent metallization on the surface of anode 110. Partial charge reduction may be carried out by electron rich groups such as aromatic groups and acidic groups disclosed above.
In some embodiments, bonding molecules 116 may comprise a top, ionic liquid binding part 116C configured to bind cations 132 and/or anions 131 of ionic liquid additive 135 in electrolyte 105. For example, embodiments represented by any of formulas I-VII which involve charged and/or polar functional groups may provide top, ionic liquid binding part 116C, e.g., lithium 3,5-dicarboxybenzenesulfonate, lithium sulfate, lithium phosphate, lithium phosphate monobasic, lithium trifluoromethanesulfonate, lithium 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonate, lithium 2,6-dimethylbenzene-1,4-disulfonate, lithium 2,6-di-tert-butylbenzene-1,4-disulfonate, 3,3′-((1,2-dithiane-4,5-diyl)bis(oxy))bis(N-hydroxypropanamide), 3,3′-((4-mercapto-1,2-phenylene)bis(oxy))bis(N-hydroxypropanamide), lithium aniline sulfonate (the sulfonate may be in any of para, meta and ortho positions) as well as poly(lithium-4-styrenesulfonate), as some non-limiting examples. Ionic liquid binding part 116C may be further configured to stabilize electrolyte-buffering zone(s) 130 as described above.
In certain embodiments, electrolyte 105 may comprise at most 5% of the at least one ionic liquid. In certain embodiments, the at least one ionic liquid may comprise sulfonylimides-piperidinium derivatives ionic liquid(s). Ionic liquid additive 135 may be selected to have a melting temperature below 10° C., below 0° C. or below −4° C., in certain embodiments.
Layer 145 may be part of the anode surface or coated thereupon, and bind at least a part of ionic liquid additive 135 to hold at least stationary portion 140A of ionic liquid additive 135 at the anode surface to support the SEI, prevent decomposition of electrolyte 105 and prevent lithium metallization on anode 100. Layer 145 of bonding molecules 116 and/or layer 140A of bonded ionic liquid additive may also provide some negative electric charge that partly reduces the lithium ion, leaving them with a partial charge δ+ and preventing full reduction and metallization of lithium on the anode surface. Layer 145 of bonding molecules 116 and/or layer 140A of bonded ionic liquid additive may be configured to support gradient 120 described in
Method 200 may comprise adding up to 20% of at least one ionic liquid to an electrolyte used in lithium ion batteries (stage 210), using metalloid-based anodes (stage 215), e.g., comprising at least one of C, graphite, Si, Sn, Ge and Al, and using the electrolyte with the ionic liquid additive to prevent lithium metallization in lithium ion batteries (stage 220). Method 200 may comprise selecting one or more ionic liquids to have cations and/or anions which are much larger than lithium ions, e.g., two to ten times the size (e.g., volume) thereof (stage 212). In certain embodiments, electrolyte 105 may comprise at most 5% of the at least one ionic liquid. In certain embodiments, the at least one ionic liquid may comprise sulfonylimides-piperidinium derivatives ionic liquid(s). Ionic liquid additive 135 may be selected to have a melting temperature below 10° C., below 0° C. or below −4° C.
In certain embodiments, method 200 may comprise forming a surface layer on the anode to bond (e.g., electrostatically and/or ionically) at least some of the ionic liquid additive(s) (stage 230), e.g., by coating the anode active material by various bonding molecules as disclosed above and/or partly or fully pre-coating and/or coating the active material using corresponding polymers (stage 235).
Method 200 may comprise carrying out the bonding during at least a first charging cycle of the cell (stage 240), possibly during several first charging and discharging cycles. In certain embodiments, the bonding of cations and/or anions may be carried out, at least partially, on the active material itself, even before the first charging cycle. The bonding of the ionic liquid to the bonding layer may be electrostatic and/or salt-like (ionic). In certain embodiments, the bonding may be at least partly covalent.
Method 200 may comprise stabilizing the SEI of the cell through the bonded portion of the ionic liquid additive(s) to the surface layer (stage 250).
Method 200 may further comprise configuring the bonding molecules to prevent contact of electrolyte solvent with anode active material, e.g., through steric hindrance (stage 260).
Method 200 may further comprise configuring the bonding molecules to have electron rich groups that provide mobile electric charge on the surface of molecules layer (stage 270), e.g., to provide an ionic conductivity path through the surface molecules layer (stage 275).
Method 200 may further comprise pre-lithiating the anode active material through an anode material anchoring part of the bonding molecules (stage 280).
Method 200 may comprise using anchored and interconnected conductive polymer molecules as the surface layer (stage 290). Alternatively or complementarily, method 200 may comprise using a thick surface layer that protrude significantly into the electrolyte (stage 295).
In the above description, an embodiment is an example or implementation of the invention. The various appearances of “one embodiment”, “an embodiment”, “certain embodiments” or “some embodiments” do not necessarily all refer to the same embodiments. Although various features of the invention may be described in the context of a single embodiment, the features may also be provided separately or in any suitable combination. Conversely, although the invention may be described herein in the context of separate embodiments for clarity, the invention may also be implemented in a single embodiment. Certain embodiments of the invention may include features from different embodiments disclosed above, and certain embodiments may incorporate elements from other embodiments disclosed above. The disclosure of elements of the invention in the context of a specific embodiment is not to be taken as limiting their use in the specific embodiment alone. Furthermore, it is to be understood that the invention can be carried out or practiced in various ways and that the invention can be implemented in certain embodiments other than the ones outlined in the description above.
The invention is not limited to those diagrams or to the corresponding descriptions. For example, flow need not move through each illustrated box or state, or in exactly the same order as illustrated and described. Meanings of technical and scientific terms used herein are to be commonly understood as by one of ordinary skill in the art to which the invention belongs, unless otherwise defined. While the invention has been described with respect to a limited number of embodiments, these should not be construed as limitations on the scope of the invention, but rather as exemplifications of some of the preferred embodiments. Other possible variations, modifications, and applications are also within the scope of the invention. Accordingly, the scope of the invention should not be limited by what has thus far been described, but by the appended claims and their legal equivalents.
This application is a continuation of U.S. application Ser. No. 16/013,969, filed Jun. 21, 2018, which is a continuation of U.S. application Ser. No. 15/447,889, filed Mar. 2, 2017, which claims the benefit of U.S. Provisional Patent Application No. 62/319,341, filed Apr. 7, 2016, 62/337,416, filed May 17, 2016, 62/371,874, filed Aug. 8, 2016, 62/401,214, filed Sep. 29, 2016, 62/401,635, filed Sep. 29, 2016, 62/421,290, filed Nov. 13, 2016, 62/426,625, filed Nov. 28, 2016, 62/427,856, filed Nov. 30, 2016, 62/435,783, filed Dec. 18, 2016 and 62/441,458, filed Jan. 2, 2017, all of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
3778254 | Cole et al. | Dec 1973 | A |
6051340 | Kawakami | Apr 2000 | A |
6492061 | Gauthier et al. | Dec 2002 | B1 |
6541156 | Fuse et al. | Apr 2003 | B1 |
6558438 | Satoh | May 2003 | B1 |
6599662 | Chiang et al. | Jul 2003 | B1 |
7192673 | Ikeda et al. | Mar 2007 | B1 |
7656120 | Neu et al. | Feb 2010 | B2 |
7906238 | Le | Mar 2011 | B2 |
7956576 | Neu et al. | Jun 2011 | B2 |
8021791 | Plichta et al. | Sep 2011 | B1 |
8945774 | Coowar et al. | Feb 2015 | B2 |
8951673 | Wessells et al. | Feb 2015 | B2 |
9406927 | Burshtain et al. | Aug 2016 | B1 |
9472804 | Burshtain et al. | Oct 2016 | B2 |
9583761 | Burshtain et al. | Feb 2017 | B2 |
9728776 | Burshtain et al. | Aug 2017 | B2 |
9871247 | Burshtain et al. | Jan 2018 | B2 |
10096859 | Burshtain et al. | Oct 2018 | B2 |
10110036 | Aronov | Oct 2018 | B2 |
10199646 | Burshtain et al. | Feb 2019 | B2 |
10199677 | Drach et al. | Feb 2019 | B2 |
10290864 | Burshtain et al. | May 2019 | B2 |
10293704 | Aronov | May 2019 | B2 |
10355271 | Burshtain et al. | Jul 2019 | B2 |
20010017531 | Sakakibara et al. | Aug 2001 | A1 |
20020122980 | Fleischer et al. | Sep 2002 | A1 |
20020146623 | Suzuki et al. | Oct 2002 | A1 |
20030039889 | Park et al. | Feb 2003 | A1 |
20040033360 | Armand et al. | Feb 2004 | A1 |
20040219428 | Nagayama | Nov 2004 | A1 |
20050019659 | Shiozaki et al. | Jan 2005 | A1 |
20050093512 | Mader et al. | May 2005 | A1 |
20070003837 | Nishimura et al. | Jan 2007 | A1 |
20070281216 | Petrat et al. | Dec 2007 | A1 |
20070284159 | Takami et al. | Dec 2007 | A1 |
20080093143 | Harrison | Apr 2008 | A1 |
20080248386 | Obrovac et al. | Oct 2008 | A1 |
20090111020 | Yamaguchi et al. | Apr 2009 | A1 |
20090179181 | Zhang et al. | Jul 2009 | A1 |
20090317637 | Luhrs et al. | Dec 2009 | A1 |
20100134065 | Iida | Jun 2010 | A1 |
20100134305 | Lu et al. | Jun 2010 | A1 |
20100159331 | Lee et al. | Jun 2010 | A1 |
20100190059 | Graetz et al. | Jul 2010 | A1 |
20110123870 | Oh et al. | May 2011 | A1 |
20110257001 | Negishi | Oct 2011 | A1 |
20110260689 | Kano | Oct 2011 | A1 |
20120045696 | Herle | Feb 2012 | A1 |
20120088155 | Yushin et al. | Apr 2012 | A1 |
20120164531 | Chen et al. | Jun 2012 | A1 |
20130040226 | Yamauchi et al. | Feb 2013 | A1 |
20130059174 | Zhamu | Mar 2013 | A1 |
20130071731 | Tokuda et al. | Mar 2013 | A1 |
20130224594 | Yushin et al. | Aug 2013 | A1 |
20130229153 | Sarkar et al. | Sep 2013 | A1 |
20130260285 | Yamauchi et al. | Oct 2013 | A1 |
20130266875 | Matsumoto et al. | Oct 2013 | A1 |
20130337314 | Essaki et al. | Dec 2013 | A1 |
20140004426 | Kerlau et al. | Jan 2014 | A1 |
20140113202 | Sun | Apr 2014 | A1 |
20140127588 | Kato et al. | May 2014 | A1 |
20140242461 | Hwang et al. | Aug 2014 | A1 |
20140295267 | Wang | Oct 2014 | A1 |
20150017515 | Jeon et al. | Jan 2015 | A1 |
20150046110 | Joe et al. | Feb 2015 | A1 |
20150221977 | Hallac et al. | Aug 2015 | A1 |
20150367747 | Decker et al. | Dec 2015 | A1 |
20160036045 | Burshtain et al. | Feb 2016 | A1 |
20160064773 | Choi et al. | Mar 2016 | A1 |
20160104882 | Yushin et al. | Apr 2016 | A1 |
20160149220 | Uhm et al. | May 2016 | A1 |
20160264124 | Hotta | Sep 2016 | A1 |
20170012279 | Burshtain et al. | Jan 2017 | A1 |
20170177121 | Herle | Oct 2017 | A1 |
20170288232 | Herle | Oct 2017 | A1 |
20170288271 | Le | Oct 2017 | A1 |
20170294643 | Burshtain et al. | Oct 2017 | A1 |
20170294680 | Burshtain et al. | Oct 2017 | A1 |
20170294687 | Burshtain et al. | Oct 2017 | A1 |
20170373513 | Aronov et al. | Dec 2017 | A1 |
20180212236 | Jacob et al. | Jul 2018 | A1 |
20180212239 | Jacob et al. | Jul 2018 | A1 |
20180212240 | Jacob et al. | Jul 2018 | A1 |
20180212439 | Aronov | Jul 2018 | A1 |
20180301757 | Burshtain et al. | Oct 2018 | A1 |
20180315990 | Paz et al. | Nov 2018 | A1 |
20190044133 | Burshtain et al. | Feb 2019 | A1 |
20190044180 | Drach et al. | Feb 2019 | A1 |
20190140258 | Burshtain et al. | May 2019 | A1 |
20190143841 | Aronov | May 2019 | A1 |
20190148713 | Burshtain et al. | May 2019 | A1 |
20190148722 | Burshtain et al. | May 2019 | A1 |
20190148774 | Kuks et al. | May 2019 | A1 |
20190157669 | Burshtain et al. | May 2019 | A1 |
20190157727 | Jacob et al. | May 2019 | A1 |
20190198912 | Sella et al. | Jun 2019 | A1 |
Number | Date | Country |
---|---|---|
2161076 | Apr 1996 | CA |
2258026 | Dec 1997 | CA |
101734675 | Jun 2010 | CN |
104577081 | Apr 2015 | CN |
1999818 | Dec 2008 | EP |
2889097 | Jul 2015 | EP |
2002-056891 | Feb 2002 | JP |
2002087807 | Mar 2002 | JP |
2006-216276 | Aug 2006 | JP |
2007-323837 | Dec 2007 | JP |
2008-053092 | Mar 2008 | JP |
2012131674 | Jul 2012 | JP |
2014-002834 | Jan 2014 | JP |
2012-121265 | Oct 2012 | KR |
2015-0015070 | Feb 2015 | KR |
200616268 | May 2006 | TW |
WO 2013040356 | Mar 2013 | WO |
WO 2014068036 | May 2014 | WO |
WO 2015114640 | Aug 2015 | WO |
WO 2015145521 | Oct 2015 | WO |
WO 2016031082 | Mar 2016 | WO |
WO 2018109774 | Jun 2018 | WO |
Entry |
---|
US 10,312,504 B2, 06/2019, Burshtain et al. (withdrawn) |
Lewandowski, “Ionic liquids as electrolytes for Li-ion batteries—An overview of electrochemical studies”, Jul. 2009, J Power Sources, 194, 601-609 (Year: 2009). |
Chaudhuri et al. “Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization, and applications” Chemical Reviews, vol. 112, No. 4, pp. 2373-2433, 2012. |
Wu et al. “Hydrogen Storage in Pillared Li-Dispersed Boron Carbide Nanotubes”, J. Phys. Chem. C, 2008, vol. 112, No. 22, pp. 8458-8463. |
Secrist “Compound Formation in the Systems Lithium-Carbon and Lithium-Boron”, Journal of the American Ceramic Society, Oct. 1967, vol. 50, No. 10. pp. 520-523. |
Suzuki et al. “Silicon nitride thin film electrode for lithium-ion batteries”, Journal of Power Sources, 2013, vol. 231, pp. 186-189. |
Konno et al. “Application of Si—C—O glass-like compounds as negative electrode materials for lithium hybrid capacitors”, Journal of Power Sources, 2009, vol. 191, No. 2, pp. 623-627. |
Hu et al. “Silicon/graphene based nanocomposite anode: large-scale production and stable high capacity for lithium ion batteries”, Journal of Materials Chemistry A, 2014, vol. 2, No. 24, pp. 9118-9125. |
Cui et al. “Carbon-Silicon Core-Shell Nanowires as High Capacity Electrode for Lithium Ion Batteries”, Nano Letters, May 8, 2009, vol. 9, No. 9, pp. 3370-3374. |
Kennedy et al. “High-Performance Germanium Nanowire-Based Lithium-Ion Battery Anodes Extending over 1000 Cycles Through in Situ Formation of a Continuous Porous Network”, Nano Letters, 2014, vol. 14, pp. 716-723. |
Hwang et al. “Mesoporous Ge/GeO2/Carbon Lithium-Ion Battery Anodes with High Capacity and High Reversibility”, ACS Nano, Apr. 13, 2015, vol. 9, No. 5, pp. 5299-5309. |
Balomenos et al. “Exergy Analysis of Metal Oxide Carbothemic Reduction under Vacuum—Sustainability prospects”, International Journal of Thermodynamics, Jun. 4, 2012, vol. 15, No. 3, pp. 141-148. |
Barton et al. “The Reduction of Germanium Dioxide With Graphite At High Temperatures”, Journal of the Less-Common Metals, 1970, vol. 22, pp. 11-17. |
Nitta et al. “High-Capacity Anode Materials for Lithium-Ion Batteries: Choice of Elements and Structures for Active Particles”, Particle Systems Characterization, 2014, vol. 31, pp. 317-336. |
Chung et al. “Electronically conductive phospho-olivines as lithium storage electrodes”, nature materials, Oct. 22, 2002. vol. 1, pp. 123-128. |
Kennedy et al. “Nanowire Heterostructures Comprising Germanium Stems and Silicon Branches as High-Capacity Li-Ion Anodes with Tunable Rate Capability”, ACS Nano, Jun. 30, 2015, vol. 9, No. 7, pp. 7456-7465. |
Kyotani et al. “Remarkable performance improvement of inexpensive ball-milled Si nanoparticles by carbon-coating for Li-ion batteries”, Journal of Power Sources, Jul. 1, 2016, vol. 319, pp. 99-103. |
Son et al. “Silicon carbide-free graphene growth on silicon for lithium-ion battery with high volumetric energy density”, Nature Communications, Jun. 25, 2015, vol. 6, No. 7393. pp. 1-8. |
Tow et al. “A Study of Highly Oriented Pyrolytic Graphite as a Model for the Graphite Anode in Li-Ion Batteries”, Journal of The Electrochemical Society, 1999, vol. 146, No. 3, pp. 824-832. |
Qi et al. “Threefold Increase in the Young's Modulus of Graphite Negative Electrode during Lithium Intercalation”, Journal of The Electrochemical Society, 2010, vol. 157, No. 5, pp. A558-A566. |
Qi et al. “Lithium Concentration Dependent Elastic Properties of Battery Electrode Materials from First Principles Calculations”, Journal of The Electrochemical Society, 2014, vol. 161, No. 11, pp. F3010-F3018. |
Wen et al. “Thermodynamic and Mass Transport Properties of “LiAl””, Solid-State Science and Technology, Dec. 1979. vol. 126, No. 12, pp. 2258-2266. |
Wu et al. “Stable Li-ion battery anodes by in-situ polymerization of conducting hydrogel to conformally coat silicon nanoparticles”, Nature Communications, Jun. 4, 2013, vol. 4, No. 1943, pp. 1-6. |
Sun et al. “Silicon/Wolfram Carbide@Graphene composite: enhancing conductivity and structure stability in amorphous-silicon for high lithium storage performance”, Electrochimica Acta, Jun. 25, 2016. vol. 191, pp. 462-472. |
Cho et al. “Zero-Strain Intercalation Cathode for Rechargeable Li-Ion Cell”, Angewandte Chemie, 2001, vol. 40, No. 18, pp. 3367-3369. |
Ngo et al. “Mass-scalable synthesis of 3D porous germanium-carbon composite particles as an ultra-high rate anode for lithium ion batteries”, Energy & Environmental Science, 2015, vol. 8, pp. 3577-3588. |
Billaud et al. “Synthesis and electrical resistivity of lithium-pyrographite intercalation compounds (stages I, II and III)”, Materials Research Bulletin, Jul. 1979, vol. 14, No. 7, pp. 857-864. |
Guriparti et al. “Review on recent progress of nanostructured anode materials for Li-ion batteries”, Journal of Power Sources, 2014, vol. 257, pp. 421-443. |
Scott et al. “Ultrathin Coatings on Nano-LiCoO2 for Li-Ion Vehicular Applications”, Nano Letters, 2011, vol. 11. pp. 414-418. |
Chen et al. “Conductive Rigid Skeleton Supported Silicon as High-Performance Li-Ion Battery Anodes”, Nano Letters, 2012, vol. 12, pp. 4124-4130. |
Kim et al. “Electrochemical properties of carbon-coated Si/B composite anode for lithium ion batteries”, Journal of Power Sources, 2009, vol. 189, pp. 108-113. |
Wang et al. “Boron-doped carbon nanotube-supported Pt nanoparticles with improved CO tolerance for methanol electro-oxidation”, Phys. Chem. Chem. Phys., 2012, vol. 14, pp. 13910-13913. |
Wang et al. “The dimensionality of Sn anodes in Li-ion batteries”, materialstoday, Dec. 2012, vol. 15, No. 12, pp. 544-552. |
Bhandavat et al. “Improved Electrochemical Capacity of Precursor-Derived Si(B)CN-Carbon Nanotube Composite as Li-Ion Battery Anode”, ACS Applied Materials & Interfaces, Oct. 2, 2012, vol. 4, pp. 5092-5097. |
Bhandavat et al. “Synthesis, Characterization, and High Temperature Stability of Si(B) CN-Coated Carbon Nanotubes Using a Boron-Modified Poly(ureamethylvinyl)Silazane Chemistry”, Journal of the American Ceramic Society, 2012, vol. 95, No. 5, pp. 1536-1543. |
Nowotny et al. “Investigations in the three systems: Molybdenum-Silicon-boron, tungsten-Silicon-boron and in which System: VS12- TaSi2”, MB. Chem., 1956, vol. 88, No. 2, pp. 179-182. |
Kasavajjula et al. “Nano- and bulk-silicon-based insertion anodes for lithium-ion secondary cells”, Journal of Power Sources, 2007, Vo. 163, pp. 1003-1039. |
Yom et al. “Improved electrochemical behavior of Tungsten Coated Silicon Monoxide-Carbon composite anode in lithium ion battery”,Abstract #1041, The Electrochemical Society 224th ECS Meeting, Oct. 27- Nov. 1, 2013. |
Liu et al. “A pomegranate-inspired nanoscale design for large-volume-change lithium battery anodes”, Nature Nanotechnology, Mar. 2014, vol. 9, pp. 187-192. |
Tao et al. “Hollow core-shell structured Si/C nanocomposites as high-performance anode materials for lithium-ion batteries”, Nanoscale, 2014, vol. 6, pp. 3138-3142. |
Song et al. “Is Li4Ti5O12 a solid-electrolyte-interphase-free electrode material in Li-ion batteries? Reactivity between the Li4Ti5O12 electrode and electrolyte”, Journal of Materials Chemistry A, 2014, vol. 2, pp. 631-636. |
Byeon “Multifunctional metal-polymer nanoagglomerates from singlepass aerosol self-assembly”, Scientific Reports, Aug. 10, 2016. pp. 1-8. |
Dhawan et al. “Development of Highly Hydrophobic and Anticorrosive Conducting Polymer Composite Coating for Corrosion Protection in Marine Environment”, American Journal of Polymer Science, 2015, vol. 5, No. 1A, pp. 7-17. |
Skameche et al. “Electrodeposition, electrochemical and optical properties of poly(3-cylopropylmethylpyrrole), a new, hydrophobic, conducting polymer film”, American Institute of Physics, 1996, vol. 354, No. 75, pp. 75-81. |
Zhao et al. “Artificial Solid Electrolyte Interphase-Protected LixSi Nanoparticles: An Efficient and Stable Prelithiation Reagent for Lithium-Ion Batteries”, Journal of the American Chemical Society, Jun. 19, 2015, vol. 137, No. 75. pp. 8372-8375. |
Gay et al. “Performance Characteristics of Solid Lithium-Aluminium Alloy Electrodes”, Journal of the Electrochemical Society, Nov. 1976, vol. 123, No. 11, pp. 1591-1596. |
Li et al. “High-rate aluminium yolk-shell nanoparticle anode for Li-ion battery with long cycle life and ultrahigh capacity” Nature Communications, Aug. 5, 2015, pp. 1-7. |
Maoz et al. “Site-Targeted Interfacial Solid-Phase Chemistry: Surface Functionalization of Organic Monolayers via Chemical Transformations Locally Induced at the Boundary between Two Solids”, Angewandte Chemie, 2016, vol. 55, pp. 12366-12371. |
Molino et al. “Hydrophobic conducting polymer films from post deposition thiol exposure”, Synthetic Metals 162, 2012, pp. 1464-1470. |
Jankovski et al. “New boron based salts for lithium-ion batteries using conjugated ligands”, Physical Chemistry Chemical Physics, May 19, 2016, vol. 18, pp. 16274-16280. |
Aurbach et al. “A short review of failure mechanisms of lithium metal and lithiated graphite anodes in liquid electrolyte solutions”, Solid State Ionics, 2002, vol. 148, pp. 405-416. |
He et al. “Effect of solid electrolyte interface (SEI) film on cyclic performance of Li4Ti5O12 anodes for Li ion batteries”, Journal of Power Sources, 2013, vol. 239, pp. 269-276. |
He et al. “Gassing in Li4Ti5O12-based batteries and its remedy”, Scientific Reports, Dec. 3, 2012, vol. 2, No. 913, pp. 1-9. |
Scharner et al. “Evidence of Two-Phase Formation upon Lithium Insertion into the Li1.33Ti1.67O4 Spinel”, Journal of The Electrochemical Society, 1999, vol. 146, No. 3, pp. 857-861. |
Doughty et al. “A General Discussion of Li Ion Battery Safety”, The Electrochemical Society Interface, 2012, pp. 37-44. |
E. McRae and J.F. Mareche “Stage dependence of the electrical resistivity of graphite intercalation compounds” Journal of Physics C: Solid Slate Physics, vol. 18, No. 8 , Apr. 5, 1983, pp. 1627-1640, Lab. de Chimie du Solide Miner., Nancy Univ., Vandoeuvre, France. |
Takatoshi Kasukabe et al. “Beads-Milling of Waste Si Sawdust into High-Performance Nanoflakes for Lithium-Ion Batteries” Sci Rep. 2017; 7: 42734. Published online Feb. 20, 2017. |
Yongxin An et al. “Effects of VC-LiBOB binary additives on SEI formation in ionic liquid-organic composite electrolyte” RSC Advances, 2012, 2, Received Nov. 6, 2011, Accepted Feb. 21, 2012, pp. 4097-4102. |
Aaron M. Chockla “Tin-Seeded Silicon Nanowires for High Capacity Li-Ion Batteries” Department of Chemical Engineering, Texas Materials Institute. Center for Nano- and Molecular Science and Technology,The University of Texas at Austin, Austin, Texas 78712-1062, United States, pp. 3738-3745, Published: Sep. 11, 2012. |
Yong-Mao Lin et al. “High performance silicon nanoparticle anode in fluoroethylene carbonate-based electrolyte for Li-ion batteriesw” Chem. Commun., 2012, 48, Received Mar. 7, 2012, Accepted May 28, 2012, pp. 7268-7270. |
Rosa Martel Danoary Tsirinomeny “Contribution to the Ultra-Fast Charging of Electric Vehicles: The Configurable Modular Multilevel Converter (CMMC)” Mots-clés de l'auteur: Ultra-fast; lithium-titanate; UFCEV; CMMC; Flex-EV. Mar. 4, 2016. |
Xu et al. “Reversible Conversion of Conducting Polymer Films from Superhydrophobic to Superhydrophilic”, Angewandte Chemie, 2005, vol. 44, pp. 6009-6012. |
Aldrich (Sigma-Aldrich MSDS Lithium hexafluorophosphate {http://www.sigmaaldrich.com/MSDS/MSDS/DisplayMSDSPage.do?country=US&language=en&productNumber=450227&brand=ALDRICH} Printed Dec. 19, 2017). |
Millipore (MSDS 1-Butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide high purity {http://www.emdmillipore.com/Web-US-Site/en_CA/-/USD/ProcessMSDS-Start?PlainSKU=MDA_CHEM-492046&Origin=PDF} date Nov. 4, 2014). |
M. Moreno et al. “Ionic Liquid Electrolytes for Safer Lithium Batteries” Journal of The Electrochemical Society, 164 (1) A6026-A6031 (2017), pp. 6026-6031. |
Andrzej Lewandowski et al. “Ionic liquids as electrolytes for Li-ion batteries—An overview of electrochemical studies” Journal of Power Sources 194 (2009) pp. 601-609. |
Marisa C. Buzzeo et al. “Non-Haloaluminate Room-Temperature Ionic Liquids in Electrochemistry—A Review” ChemPhysChem 2004, 5, pp. 1106-1120. |
International Search Report and Written Opinion of PCT Application No. PCT/IL2017/050424, dated Jul. 13, 2017. |
Office action of U.S. Appl. No. 15/414,655 dated Aug. 14, 2017. |
Office action of U.S. Appl. No. 15/447,784 dated Jun. 22, 2017. |
Office action of U.S. Appl. No. 15/447,889 dated Jul. 17, 2017. |
Office action of U.S. Appl. No. 15/480,919 dated Jul. 5, 2017. |
Office action of U.S. Appl. No. 15/414,655, dated May 9, 2017. |
Office action of U.S. Appl. No. 15/287,292, dated Dec. 15, 2017. |
Office action of U.S. Appl. No. 15/447,784, dated Dec. 28, 2017. |
Office Action for U.S. Appl. No. 15/480,888, dated Oct. 1, 2018. |
Office Action for U.S. Appl. No. 15/853,885, dated Feb. 23, 2018. |
Office action of U.S. Appl. No. 15/480,888 dated Sep. 13, 2017. |
Office action of U.S. Appl. No. 15/447,784 dated Oct. 19, 2017. |
Office action of U.S. Appl. No. 15/582,066 dated Aug. 21, 2017. |
Office Action for U.S. Appl. No. 15/783,586, dated Apr. 6, 2018. |
European Search Report for Application No. EP17206661.5, dated Apr. 16, 2018. |
Office Action for U.S. Appl. No. 15/447,889, dated May 24, 2018. |
Office Action for U.S. Appl. No. 15/480,904, dated Oct. 29, 2018. |
Office Action for U.S. Appl. No. 15/480,911, dated Nov. 8, 2018. |
Office Action for U.S. Appl. No. 15/480,922, dated Nov. 8, 2018. |
Office Action for U.S. Appl. No. 15/844,689, dated Jan. 31, 2018. |
Office Action for U.S. Appl. No. 15/844,689, dated Apr. 16, 2018. |
Office Action for U.S. Appl. No. 15/844,689, dated May 23, 2018. |
Notice of Allowance for U.S. Appl. No. 15/844,689, dated Sep. 4, 2018. |
Office Action for U.S. Appl. No. 16/254,644, dated Mar. 1, 2019. |
Notice of Allowance for U.S. Appl. No. 16/258,728, dated Mar. 6, 2019. |
Office Action for U.S. Appl. No. 16/268,527, dated Apr. 2, 2019. |
Office Action for U.S. Appl. No. 15/853,885, dated May 1, 2019. |
Office Action for U.S. Appl. No. 16/243,190, dated Jun. 12, 2019. |
Number | Date | Country | |
---|---|---|---|
20200006811 A1 | Jan 2020 | US |
Number | Date | Country | |
---|---|---|---|
62435783 | Dec 2016 | US | |
62319341 | Apr 2016 | US | |
62337416 | May 2016 | US | |
62371874 | Aug 2016 | US | |
62401214 | Sep 2016 | US | |
62401635 | Sep 2016 | US | |
62421290 | Nov 2016 | US | |
62426625 | Nov 2016 | US | |
62427856 | Nov 2016 | US | |
62441458 | Jan 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16013969 | Jun 2018 | US |
Child | 16565500 | US | |
Parent | 15447889 | Mar 2017 | US |
Child | 16013969 | US |